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ABSTRACT  
 
 
In many developing countries with advanced stages of the nutrition transition, the 
burden of coronary artery disease (CAD) has shifted from the rich to the poor. Much of 
this transition is caused by changes in lifestyle, in particular: dietary changes, an 
increase in weight and obesity, a decrease in physical activity, high levels of stress, and 
increasing tobacco and alcohol consumption. However, we have come to appreciate a 
prominent role for inflammation in atherosclerosis and its complications.   
 
Globalization, urbanization and Westernization of lifestyle will increase the socio-
economic burden posed by non-communicable diseases in middle-to-low-income 
countries.  In South Africa, it is mainly the African population that is experiencing rapid 
urbanization and the nutrition transition.  
 
Reliable ischaemic heart disease (IHD) mortality data are not available for the black 
population of South Africa.   
 
The purpose of this thesis was: to determine whether factors such as inflammation, 
postprandial lipaemia and hyperglycaemia are important determinants in black patients 
with documented CAD (with no previous known history of diabetes mellitus) and their 
age matched controls; to assess the prevalence of the metabolic syndrome (MS) in black 
patients and abnormal glucose regulation on black patients with CAD; and to compare 
the metabolic syndrome prevalence rates using the National Cholesterol Education 
Program Adult Treatment III (NCEP: ATP III) and International Diabetes Federation 
(IDF) definitions.  
 
Socio-economic status, anthropometric data, glucometabolic variables, LDL particles 
and MS prevalence rates were measured using 40 patients and 20 controls. The patients 
were selected consecutively on the basis of a coronary angiogram performed during the 
preceding 24 months. All subjects had significant CAD, which was defined as more 
than 50% lesions in one or more major coronary arteries. Subjects with severe 
hypercholesterolaemia, defined as an untreated total cholesterol level over 7.5 mmol/l, 
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were excluded from the study. Those subjects with diabetes mellitus or HIV/AIDS were 
excluded from the study.  
 
Paper 1, titled ‘Metabolic syndrome, undiagnosed diabetes mellitus and insulin 
resistance are highly prevalent in urbanized South African blacks with coronary artery 
disease’, demonstrated a high prevalence of MS in black patients with established CAD.  
To our knowledge, this is the first report from South Africa that documents the 
prevalence of the syndrome in black patients with CAD.  Almost all of our patients had 
previously diagnosed hypertension (95%). The second most frequent risk factor was an 
elevated glucose concentration, which was seen in half the patient cohort.  The 
importance of obesity, particularly abdominal obesity expressed as waist circumference 
(WC), is well documented as a risk factor for MS. An unexpected outcome of our study 
was that half of the patients had abnormal glucose regulation, despite the exclusion of 
previously diagnosed DM. This high prevalence was revealed by the oral glucose 
tolerance test (OGTT).    
 
Paper 2 compares the MS prevalence estimates, as defined by NCEP: ATP III and IDF, 
amongst urbanized black South Africans with CAD. The IDF proposed a single 
unifying definition in 2005, as different definitions used different sets of criteria; this 
led to confusing and inconsistent estimations of MS prevalence. The new definition 
standardizes the criteria for the diagnosis of MS and offers a fresh assessment of the 
syndrome. The main findings that arose from the study were that both definitions 
generated similar prevalence estimates of MS and the two definitions similarly 
identified the presence or absence of MS in more than 80% of patients.  This study 
demonstrated that postprandial lipaemia and hyperglycemia were common in black 
CAD patients.  Small dense LDL particles were highly associated with CAD.  Fasting 
triglyceride concentrations was the strongest determinant. Prolonged exposure of the 
endothelium to TG–rich atherogenic remnant particles might be the reason why 
postprandial increases in TG account for greater CAD risk.  
 
Paper 3 assessed postprandial lipaemia in black CAD patients with and without 
metabolic syndrome. This study was the first to contribute information about 
postprandial lipaemia and hyperglycaemia in urbanized South African blacks with 
CAD. Fasting lipid profiles and postprandial responses to the oral fat load were similar 
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in patients with and without metabolic syndrome.  A possible explanation might be that 
because patients in both groups had established CAD, they exhibited some of the 
underlying features of CAD, such as atherogenic dyslipidaemia. The main finding was 
that postprandial lipaemia was common in black CAD patients, including patients with 
metabolic syndrome. Fasting triglycerides concentration was the strongest determinant. 
Small, dense LDL particles were highly associated with CAD.  
 
Paper 4 reports on the assessment of postprandial hyperglycaemia in urbanized blacks 
with and without CAD. Results showed that glucose AUC was significantly higher in 
the patients than in control subjects and 120 min. glucose, followed by 0 min. glucose 
concentration, were the strongest determinants of postprandial hyperglycaemia. Our 
study demonstrated that as glucose tolerance declined across the normal glucose 
tolerance, impaired glucose tolerance and diabetes mellitus categories, peak glucose 
concentrations occurred later in the oral glucose tolerance test; insulin and proinsulin 
responses were also delayed. A comparison between CAD patients and control subjects 
drawn from the same ethnic population verified that abnormal glucose tolerance and 
insulin resistance were more prevalent in the patients with CAD.  
 
Paper 5 aimed at investigating whether carotid intima-media thickness (CIMT) is a 
predictor of CAD in South African black patients.  The results showed that CIMT 
correlated with evidence of angiographically proven CAD.  The findings of this study 
need to be considered within the context of its limitations, i.e. the low number of 
women and some bias towards only hospital referred CAD patients.  It was not our 
intention to recruit more men than women, but because CAD is more prevalent in men, 
the majority of participants happened to be male. Performance of the OGTT and 
hyperinsulinaemic euglycaemic clamp technique is time consuming and requires 
considerable laboratory resources; therefore a relatively small number of patients and 
control subjects were studied. These limitations do not detract from the overall 
conclusions.  
 
Paper 6 evaluated markers of inflammation in black CAD patients, some of whom had 
MS. Leptin was the only marker that increased with additional MS criteria. Elevated hs-
CRP concentrations indicated an inflammatory state in CAD patients. Association of 
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leptin with BMI, waist circumference (WC) and hs-CRP revealed a close link with MS, 
obesity and inflammation in urban black South African CAD patients. 
 
Paper 7 investigated the role of diet, socio-demographics and physical activity in a 
black South African population with CAD, compared to a healthy control group. While 
diet is known to be affected by urbanisation, differences in dietary intake were observed 
between the two urban groups, despite the similarity in their socio-demographic profile.  
 
The study highlighted the clinical relevance of MS, its likely impact on morbidity and 
mortality, and that its identification is, therefore, important in risk assessment of 
patients with CAD.  Increasing recognition of MS is, therefore, an initial step in 
addressing the metabolic problems associated with the syndrome.  Furthermore, it was 
shown that a preponderance of small, dense LDL particles was highly associated with 
CAD in black patients.  Although CAD prevalence is still low at this stage, it is likely to 
increase rapidly among urban dwellers as they adopt a Western lifestyle.  
 
                                 
 . 
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CHAPTER 1:   INTRODUCTION  
 
 
1.1    HYPOTHESES / RESEARCH QUESTIONS 
 
1. Is there a difference in the biochemical risk factor profile of black subjects with 
coronary heart disease (CAD), compared to age matched black controls without 
CAD? 
2.   What are the prevalence / incidence rates of diabetes, insulin resistance and the 
metabolic syndrome in SA presenting with CAD? 
3.   Are there post prandial glucose differences in the black CAD subjects compared 
to the age matched controls without CAD?   
4.  Are there post prandial lipid differences in the lipids and lipoproteins of black 
CAD subjects compared to the age matched controls without CAD?   
5.  Is Carotid Intima Media Thickness (CIMT) a predictor of CAD in South African 
black patients?   
6.  What is the influence of social factors and lifestyle on the onset of CAD?   
 
1.2 RATIONALE OF THE STUDY    
 
Rapid economic development and the consequent improvement in living conditions, 
nutrition, and health care have resulted in declines in infant mortality and deaths from 
infectious diseases and therefore in increases in life expectancy in many developing 
countries including China. (1) In 2001, cardiovascular disease (CVD) was already the 
No.1 cause of death worldwide, yet little global attention has been to the challenge of 
reducing this burden in developing countries, where it is on the rise. (2) In 2006-2007 
the World Health Organization (WHO) allocated 87 % of its total budget to infectious 
diseases, 12 % to non-communicable diseases, and less than 1 % to injuries and 
violence. (3) CVD and other chronic diseases remain excluded from the United 
Nation’s Millennium Development Goals (MDG) three infectious diseases –
tuberculosis, human immunodeficiency virus (HIV) infection or the acquired 
immunodeficiency syndrome (AIDS), and malaria –have attracted the greatest attention 
from international donors, but together they are responsible for only 10 % of the deaths 
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in the world. (4) If nothing is done to reduce the risk of chronic diseases, an estimated 
US $ 84 billion of economic production will be lost from heart disease, stroke, and 
diabetes alone between 2006 and 2015. (5) This will be  principally due to decline in 
deaths occurring in infancy, childhood, and adolescence and is  related to more 
effective public health responses to perinatal, infectious and nutritional deficiency 
disorders, and to improved economic indicators such as per capita income. (6) Recent 
lifestyle changes in developing countries (7) and urbanization have resulted in the view 
that coronary heart disease will become the leading cause of death worldwide. (8) The 
epidemiological transition in turn, is predicted upon demographic and nutritional 
transitions occurring as a result of socio-economic development and increasing 
globalization that alter the determinants and risk factors for CVD and hence the patterns 
of CVD. (9)  
 
 There are very few studies at all that specifically report on the form, characteristics and 
extent of CAD among Black Africans . In black Africans, CAD has, until recently, been 
rather uncommon. (10) However, although still relatively uncommon, the incidence is 
thought to be increasing, due to changing socio-economic conditions. (11) In 1959 and 
1960, an autopsy study at the Baragwanath Hospital (CHBH) in Soweto, South Africa, 
reported only one case of CAD; in 1976, fourteen cases were reported. (12) 
Historically, clinical coronary artery disease has also been remarkably rare in black 
South Africans.  Records from South Africa’s largest hospital, the CHBH showed that 
in the early 1990s, on average, approximately 70 black patients with CAD were 
admitted annually. (13)   
 
A recent review of patients who underwent coronary angiography at CHBH revealed 
that in 2002 the number with significant CAD had increased somewhat, to 85 patients.  
 
Presently approximately 150 patients are admitted annually to CHBH with acute 
coronary syndromes (Sliwa). However, there are few empirical studies on the changing 
profile of CVD in black Africans, especially those in urban settings.  White South 
Africans have rates of CAD that are amongst the highest in the world and South 
Africans of Indian descent also have high CAD rates.  The increase in the volume of 
cases has been far less than expected, however, and CAD remains an unusual cause of 
admission in black patients.  
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Table 1:   Leading cause of death in 2001  
Low and middle income countries
Cause Deaths (millions) % of total deaths Cause % of total deaths Deaths (millions)
High income countries
Ischaemic heart disease
Cardiovascular disease
Trachea, bronchus, lung cancers
Lower respiratory infections
Chronic obstructive pulmonary disease
Colon and rectum cancers
Alzheimer’s disease and other dementias
Diabetes mellitus
Breast cancer
Stomach cancer
1.36
0.78
0.46
0.34
0.30
0.36
0.21
0.20
0.16
0.15
17.13%
9.9%
5.8%
4.4%
3.8%
3.3%
2.6%
2.6%
2.0%
1.9%
5.70
4.61
3.41
2.55
2.49
2.38
1.78
1.59
1.21
1.07
11.8%
9.5%
7.0%
5.3%
5.1%
4.9%
3.7%
3.3%
2.5%
2.2%
Ischaemic heart disease
Cardiovascular disease
Lower respiratory infections
HIV/AIDS
Perinatal conditions
Chronic obstructive pulmonary disease
Diarrhoeal diseases
Tuberculosis
Malar ia
Road traffic accidents
Ten leading causes of death by income groups, 2001
1
2
3
4
5
6
7
8
9
10
Lancet 2006;367:1747-57
 
This low prevalence of CAD prevails in South Africa despite considerable 
Westernization of lifestyle and the accompanying rise in risk factors for CAD, such as 
obesity, atherogenic dyslipidaemia, hypertension and type 2 diabetes mellitus (DM). 
(14) However, there are few empirical studies on the changing profile of CVD in black 
Africans, especially those in urban settings. (15) Furthermore, there are very few 
studies at all that specifically report on the form, characteristics and extent of CAD 
among this group. (16) As noted above, historically, CAD amongst black Africans is 
indeed uncommon.     
 
Increasing rates of CAD amongst this group have been observed and recently reported. 
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A large body of epidemiological studies, including the Interheart study, clearly 
demonstrated the emergence of cardiovascular disease epidemic in low-to-middle 
income countries. Ischaemic heart disease and cerebrovascular disease (stroke) were 
leading cause of death in high income and low-and-middle- income countries (see Table 
1 above). (17)  
 
Data presented in the report “Chronic Diseases of Lifestyle in South Africa 1995 – 
2005”, shows that most of the South African population is at risk of a chronic disease 
profile related to the Western lifestyle. (18) In the Interheart study, recently published 
in the Lancet, a standardized case control of similar cohorts in 52 countries examined 
the importance of risk factors for CAD on a worldwide basis. (19) On an adjusted basis, 
the following five modifiable risk factors were found to be most predictive of this 
event: smoking, raised apoB/apoA1 ratio, diabetes, hypertension and obesity. (20)  
 
Global trade and marketing developments are driving the nutrition transition towards 
diets with a high proportion of saturated fat and sugars. This diet, in combination with 
tobacco use and little physical activity, leads to population-wide atherosclerosis.  The 
epidemiological transition, change in the metabolic cardiovascular risk factors and the 
emerging coronary artery disease within the black population have been not receive the 
necessary attention, until thus far. South Africa cannot escape the public health impact 
of globalization and urbanization.  
 
1.2.1  Metabolic risk factors   
 
The constellation of the metabolic abnormalities comprising central obesity, raised 
triglycerides (TG), reduced high-density lipoprotein (HDL) cholesterol, raised blood 
pressure (BP) and raised fasting glucose is referred to as metabolic syndrome (MS). 
(21) In the past decade, several panels of experts have attempted to provide a definition 
of the diagnostic criteria for MS.  The WHO published the first definition in 1998; this 
was soon modified by the European Group for the Study of Insulin Resistance. In 2001, 
the NECP: ATPIII issued its definition. (22) Subsequently, the American College of 
Endocrinology released a position statement on MS.  Each of these definitions used 
differing sets of criteria, which led to confusing and inconsistent estimations of the 
prevalence of MS.  
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Table 2:  Current definitions of Metabolic Syndrome   
 
WHO 1999 EGIR 1999 ATPIII 2001 IDF 2005 
Diabetes or impaired 
glucose tolerance or 
insulin resistance* 
Insulin resistance* or 
hyperinsulinaemia 
(only non-diabetic 
subjects) 
3 or more risk factors  Central obesity 
Waist circumference$† - 
ethnicity specific  
Plus 2 or more of the 
following: 
Plus 2 or more of the 
following: 
Plus 3 or more of the 
following: 
Plus any two of the 
following: 
 
1. Obesity: BMI>30 
kg/m2 or Waist Hip 
ratio >0.9 (M) >0.85 
(F) 
2. Dyslipidaemia: 
Triglycerides ≥1.7 
mmol/l or HDL-C 
<0.9 mmol/l (M) 
<1.0 (F) mmol/l  
3. Hypertension: Blood 
pressure 
≥140/90mmHg or 
medication 
4. Microalbuminuria: 
Albumin excretion 
≥20 μg/min 
 
1.  Central obesity: 
Waist 
circumference 
≥94cm (M), ≥80cm 
(F) 
2.  Dyslipidaemia: 
Triglycerides >2.0 
mmol/l or HDL-C 
<1.0 mmol/l 
3.  Hypertension: 
Blood pressure 
≥140/90 mmHg 
and/or medication 
4.  Fasting plasma 
glucose ≥6.1mmol/l 
 
1.  Central obesity: 
Waist 
circumference     
>102cm (M), 
>88cm (F) 
2.  Hypertri-
glyceridaemia: 
Triglycerides ≥1.7 
mmol/l 
3.  Low HDL-C: 
<1.0 mmol/l  
   (M), <1.3 mmol/l 
(F) 
4.  Hypertension: 
Blood pressure 
≥130/85mmHg or 
medication 
5.  Fasting plasma 
glucose ≥6.1 
mmol/l 
1. Raised 
triglycerides≥ (1.7 
mmol/l ) or specific 
treatment for this 
lipid abnormality 
2. Reduced HDL-C 
< 1.03 mmol/l 
(M) <1.29 mmol/l 
(F) or specific 
treatment for this 
abnormality 
3. Hypertension: 
130/85mmHg or 
medication 
4. Fasting plasma 
glucose ≥5.6 
mmol/l or 
previously 
diagnosed type 2 
diabetes^ 
     
 
In response to this controversy, the International Diabetes Federation (IDF) proposed a 
single unifying definition in 2005. (23) The focus of the new definition is central 
obesity, (24) as assessed by waist circumference (see Table 2 above). It varies from the 
earlier NECP: ATPIII definition in that it incorporates specific waist circumference 
(WC) cut-offs for men and women from different ethnic groups.   
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While the pathophysiology of MS and each component is not fully understood, obesity 
and insulin resistance are thought to be important causative factors. (25)  
 
Abdominal obesity is the form of obesity most strongly associated with MS; it presents 
clinically as increased WC. Atherogenic dyslipidaemia describes the combination of 
raised TG and reduced concentrations of HDL cholesterol. (26) Hypertension, often 
regarded as being less ‘metabolic’ than other components, usually coincides with 
obesity and commonly occurs in insulin–resistant individuals. Insulin resistance is 
present in the majority of patients with MS, many of whom develop impaired glucose 
tolerance (IGT). (27) When IGT progresses to DM, an elevated glucose concentration 
constitutes a major independent risk factor.  The increased risk for CAD, however, is 
already present at modestly elevated levels of blood glucose that are well below the 
threshold for the diagnosis of DM. (28) Indeed, a recent survey done across Europe on 
CAD patients without previously diagnosed DM reported a high prevalence of both IGT 
(36%) and newly detected DM (18%). (29) The conceptual importance of the MS is, 
therefore, to indicate that these various factors are more likely to occur together rather 
than separately; when they cluster, they are related to increased risk of CVD morbidity 
and mortality. 
 
Much interest is currently being focused on the striking global increase in the 
prevalence of MS.  However, although it is acknowledged that the overall prevalence of  
MS is increasing globally, the rates vary widely among different populations across the 
world. Japan has one of the lowest prevalence rates (only 6%), followed by 11% in 
Finland, 27% in Mexico and 32% in India. (30) Prevalence is higher in the USA, where 
rates of 34% and 39% were reported for black and white Americans respectively. In 
Africa, an even higher prevalence rate of 43% was found in black Zimbabweans. (31) 
However, there remains a paucity of information about the prevalence of MS and 
abnormal glucose regulation in the inhabitants of sub-Saharan Africa.   
 
One of the main aims of this thesis was to assess the prevalence of MS in the South 
African emerging black population with established CAD. An additional aim was to 
assess the prevalence of abnormal glucose regulation in these patients, who had no 
previously known DM.       
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 1.2.2     Lipids  
 
The role of lipids and lipoproteins in the pathogenesis of atherosclerosis was first 
described more than 50 years ago.  Dyslipidaemia is a major, if not the major, risk 
factor for CAD.  An elevated LDL-cholesterol level appears to be the primary CAD risk 
factor, as some elevation of LDL-cholesterol seems to be necessary for the development 
of CAD. Lowering LDL cholesterol has now been conclusively shown to decrease 
CAD events as well as total mortality. (32)   
 
Although increased LDL cholesterol appears to be the primary CAD risk factor, small 
dense particles in the LDL sub-fraction are particularly atherogenic and have also been 
implicated in atherogenesis. (33) Small, dense LDL particles are more susceptible to 
oxidation than large, buoyant LDL particles and they are retained to a higher degree in 
the arterial wall. Furthermore, small, dense LDL particles display reduced binding to 
LDL receptors and remain in the circulation system for longer periods of time. These 
LDL particles are, therefore, subject to a greater degree of structural modification, 
which, in turn, may increase their atherogenic potential. (34)   
 
Elevated fasting triglyceride levels also appear to be an independent risk factor for 
CAD in epidemiological studies. (35) HDL-cholesterol, on the other hand, mediates 
reverse cholesterol transport and is a negative risk factor for CAD. (36) However, the 
measurement of serum lipids and their carrier lipoproteins, such as apolipoprotein B 
and A1, cannot identify all patients with CAD. (37)    
 
In addition, studies by Fraser and Zilversmit in the 1970s led to the postprandial theory 
of atherosclerosis. (38) This hypothesis proposed that atherosclerosis is a postprandial 
phenomenon that largely depends on the metabolic response to the ingestion of food. 
The number of meals consumed and the long duration of postprandial lipaemia lead to a 
continual fluctuation in the degree of lipaemia throughout the day. Evidence is 
accumulating that many patients with established CAD also have postprandial 
abnormalities in lipid metabolism. This relationship has been reported by several 
researchers.  
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All of these studies showed that CAD patients had elevated TG concentrations as well 
as a prolonged postprandial response after a fatty meal. Postprandial lipaemia is 
characterized by a marked increase in plasma levels of TG and TG–rich lipoproteins.  
This is accompanied by a reduced concentration of high density lipoprotein (HDL) 
cholesterol and a modestly raised level of low density lipoproteins (LDL) cholesterol. 
(39)   
 
 An enhanced TG rise postprandially also occurs in other conditions that are associated 
with an increased risk of vascular disease, such as obesity, hypertension, DM and the 
metabolic syndrome.  In fact, postprandial lipaemia is now considered to be another 
characteristic feature of MS. A further link between postprandial lipaemia and MS is 
that an elevated fasting TG concentration is accompanied by abdominal obesity.  These 
two risk factors, together with hypertension, low HDL cholesterol and raised plasma 
glucose concentrations, are diagnostic criteria for this syndrome.   
 
Evidence is accumulating that many patients with established CAD also have 
postprandial abnormalities in lipid metabolism (40); this relationship has been reported 
by several researchers. All of these studies showed that CAD patients had elevated TG 
concentrations as well as a prolonged postprandial response after a fatty meal.     
 
The relationship between insulin resistance and CAD and its risk factors has only been 
investigated occasionally in a black African setting. (41) Patients with CAD tend to be 
insulin resistant and display delayed and higher peak plasma triglyceride levels after a 
fat load. (42) Insulin resistance and postprandial lipaemia may, therefore, be important 
risk factors for CAD.  Relatively little is known, however, about the occurrence of 
postprandial lipaemia in urbanized black South Africans.  
 
1.2.3    Inflammation, atherosclerosis and CAD  
 
Atherosclerosis is a multifactorial disease for which numerous pathogenetic concepts 
have been proposed. (43) Many patients with coronary atherosclerosis lack 
conventional risk factors, suggesting that there are additional, unidentified factors that 
contribute to vascular injury. (44) For example: evidence indicates that microorganisms 
may play a role in the pathogenesis of the disease. Epidemiological studies indicate that 
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infectious agents may predispose patients to atherosclerosis and its adverse clinical 
events. (45)   
 
Inflammation also appears to play an important role in the onset development and 
evolution of atherosclerotic lesions.  Laboratory and pathological data support the idea 
that inflammation has a role in both the initiation and progression of atherosclerosis, 
whilst chronic inflammation of the artery wall is a principal driving force behind the 
development of atherosclerosis. (46)  
 
Infections may predispose to atherosclerosis by inflicting endothelial injury. Organisms 
implicated are intracellular pathogens, including viruses such as: cytomegalovirus 
(CMV), herpes simplex virus-1 (HSV-1) and hepatitis A virus.  
 
Virtually all regional acute myocardial infarcts are caused by thrombosis developing on 
a culprit coronary atherosclerosis. Vascular cell adhesion molecule-1 (VCAM-1) binds 
precisely the types of leukocytes found in early human and experimental atheroma, the 
monocyte and T lymphocyte. (47)   
 
Thrombus formation is the proximate cause of myocardial infarction, but 
atherosclerosis, the chief underlying cause, is a chronic disease that progresses over 
decades. Endothelial dysfunction is one of the earliest manifestations of atherosclerosis. 
(48)    
 
A number of epidemiological studies have shown that the acute phase reactant, CRP, is 
an important risk marker for atherosclerosis and coronary heart disease. Elevated serum 
levels of CRP have been widely considered to be non-specific but sensitive markers of 
acute inflammatory response. (49) However, there are few data to indicate whether 
inflammation increases the risk of myocardial infarction, stroke and venous thrombosis. 
 
 The mechanism that relates the level of CRP to atherothrombosis remains unclear.    
         
1.2.4      Nutrition and CAD   
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The major cardiovascular diseases have at their core atherosclerosis and hypertension, 
both of which are profoundly affected by diet. (50) Prospective studies suggest that a 
high trans fat intake is associated with an increase in heart disease rates. (51) Increased 
consumption of fruit and vegetables has been shown to be associated with a reduced 
risk of stroke in most epidemiological studies. (52)   
 
Schutte et al, (53) have shown that the underlying cause of the decreased health status 
of black people is due to the Western lifestyle adopted in an urban environment. 
Urbanization and the nutrition transition in South Africa are accompanied by an 
increase in the CAD risk factors in Africans. (54) During the period 1993 - 1996, the 
percentage of urbanized black South Africans increased from 35.8 to 43.3%. (55)   
 
CAD is a major health problem in all population groups of South Africa.  Apart from 
the black South Africa population, epidemiological transition has been found in the 
Chinese. (56) Vorster et al, (57) demonstrated the nutritional transition in black South 
African population groups is due to: a decreased intake of the staple food, maize 
porridge; and an increased intake of animal derived foods. This has resulted in increases 
in serum total cholesterol, LDL cholesterol and plasma fibrinogen. All are accepted risk 
factors of cardiovascular diseases that can be influenced by diet.  
 
It is commonly believed that an increased intake of total dietary fiber reduces 
postprandial glucose responses and lowers total and LDL cholesterol levels. (58) A diet 
high in total dietary fiber and the consumption of a soluble dietary fiber significantly 
decreased levels of the inflammatory marker C- reactive protein.  
 
Foods of high density are often selected by the poor because of cost and availability, 
whereas fruit and vegetables are not readily available to the poor.        
 
1.2.5    Intima-media thickness, atherosclerosis and CAD   
 
Atherosclerosis is a generalized disease of the arterial wall, which may progress or 
regress depending on a plethora of factors. (59) Atherosclerosis is a protracted and 
lifelong progressive disease of the arterial wall that leads to cardiovascular disease.   
 
 
 
11
Thickening of the intima-media is commonly recognized as the initial stage in the 
development of atherosclerosis. (60) CIMT is an intermediate phenotype for early 
atherosclerosis. (61) Traditional risk factors, such as male gender, ageing, high blood 
cholesterol, being overweight, elevated blood pressure, diabetes and insulin resistance 
and cigarette smoking are positively associated with carotid IMT in observational and 
epidemiological studies. (62)   
 
Imaging progression and regression of atherosclerosis might be used as a surrogate 
marker for cardiovascular disease occurrence. (63) Common and internal carotid IMT 
can be viewed as an estimate of atherosclerosis quantity. Intima-media thickness of 
large artery walls, especially carotid, can be assessed by B-mode ultrasound in a 
relatively simple way and represents a safe, inexpensive, precise and reproducible 
measure. Vascular markers of atherosclerotic burden allow atherosclerosis to be studied 
in the sub-clinical phase of the disease and facilitate the assessment of new therapies for 
modifying coronary heart disease risk factors. (64) A number of longitudinal studies 
have examined the relationship between IMT and future events, mostly frequently the 
incidence of cardiac events and cerebrovascular events. No studies have been done on 
the South African black population with coronary artery diseases.   
  
1.3    LITERATURE REVIEW OF CORONARY ARTERY DISEASE IN 
AFRICA  
 
Opinions and reports suggest that as long as Africa remains impoverished it is unlikely 
that CAD will emerge as a significant health problem. The Interheart Africa study, 
which examined the impact of modifiable CAD risk factors on myocardial concluded 
that there were low numbers of myocardial infarction cases. In Kenya there was one 
case of autopsy confirmed myocardial infarction among 2000 adult admissions at a 
large regional hospital in 1960. (65) Analysis of the records of 3645 autopsies 
performed in Accra in Ghana over a 33 year period (1921 - 1953) revealed only thirty 
cases of coronary heart diseases.   
 
However, with growing urbanization and economic development, the rates may 
increase and resemble those seen in South Africa. (66) Several studies have shown that 
urbanization and nutrition in South Africa is accompanied by an increase in the CAD 
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risk factors in Africans. Urbanization is, of course, linked with economic development 
and education level, being the main reasons why people move from under-developed, 
rural areas with limited job and education opportunities to more developed urban areas.  
 
In South Africa, recent surveys have confirmed both the high prevalence of 
hypertension among Zulu and Xhosa subjects and an urban rural gradient. In a study, 
done at Johannesburg Hospital, Seftel and Kew found that a total of 24 black patients 
with myocardial infarction were admitted during the 4 year period 1965 - 1968.  These 
authors concluded that the prevalence had increased as a result of a Western life style in 
an urban environment. (67)    
 
The THUSA (Transition and Health during Urbanization of South Africans) study was 
a cross sectional epidemiological study that looked at how the factors associated with 
urbanization influences the cardiovascular system as a whole. One of its conclusions 
was that factors associated with urbanization include elevated blood pressure. A classic 
rise in blood pressure was observed in the African male who had transversed from a 
monoculture, rural environment to a multi-cultural urban environment.  The urban 
group also had a higher abdominal fat content.  
 
Lipid levels increase with urbanization in both men and women. The BRISK study (68) 
conducted by Krisela Steyn (Medical Research Council (MRC) in the Cape Peninsula) 
also examined the risk factors for coronary heart disease in black populations. This was 
a cross sectional study of 986 black people aged 15 - 64 years, living in the Cape 
Peninsula. Findings included: with rapid urbanization of the black population there is a 
concern over a concomitant adoption of the lifestyles of typical, industrialized 
populations; this in turn raises the possibility of increased mortality from IHD and CVD 
in the future.  
 
The overall risk profile identified in the BRISK study shows that the black, male, urban 
population of the Cape Peninsula already has considerable IHD and about 30.8% of 
males aged 25 years and above have at least one risk factor. (69) The high prevalence of 
obesity among older black women, (70) has partially contributed to the development of 
hypertension in this group. (71)  
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The Interheart Africa study remains the only major epidemiological study of note done 
on coronary artery disease in Africa: 578 acute MI cases from nine sub-Saharan African 
countries were recruited in a period of 4 years (1999 - 2003).  The Interheart Africa data 
showed for the first time that only five risk factors account for 89.2% of the risk for MI, 
i.e.: tobacco smoking, hypertension, diabetes, abdominal obesity and lipoprotein 
ApoB/ApoA-1.  
 
Consequently, the data from this report contradicts the theory that black African people 
with exposure to the known cardiovascular risk factors are immune to developing AMI. 
(72) Unhealthy lifestyles (73) and the resultant emerging CVD risk factors impart at 
least the same level of risk for AMI (74) as that found in the overall INTERHEART 
study.  The major limitation of the INTERHEART study was the small sample of black 
African myocardial infarction cases.  
 
I deliberately chose to exclude the PURE and HEART Of Soweto Studies. It would be 
too premature to comment on them as they are still on the infancy stages. Another study 
worth mentioning is the Agincourt surveillance by the MRC/WITS Rural Public Health 
and Health Transitions Research Unit since 1992. (75) The research findings on stroke 
and cardiovascular disease indicate a prevalence of hypertension in men and women; 
pronounced obesity in women; more frequent smoking in men than women and modest 
cholesterol and high HDL-cholestrol concentrations. The studies are still on going. 
However the above studies, do not fully address the question, what do we know about 
the burden of cardiovascular disease in South Africa?  
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CHAPTER 2:    RESEARCH DESIGN  
 
 
This was a retrospective study. Forty black patients (33 males and 7 females) with 
angiographically confirmed CAD were recruited over 24 months. All the patients had 
significant CAD, which was defined as more than 50% lesions in one or more major 
coronary arteries demonstrated on coronary angiography.   Twenty subjects (13 men 
and 7 women), who were matched with the patients for age, body mass index (BMI), 
waist circumference and waist to hip ratio were used as controls. Patients and control 
subjects were classified according to the number and extent of lesions in coronary 
arteries, which were verified by a coronary angiogram performed in the preceding 24 
months.  None of the control subjects had evidence of coronary atherosclerosis on 
coronary angiography.  Patients who had a previous myocardial infarction (MI) were at 
least three months post-MI before the study started. The majority of patients and control 
subjects had moderate hypertension and they were taking anti-hypertensive medication 
at the time of the study.   
 
Patients who had a dominant risk factor, such as severe hypercholesterolaemia or 
previously diagnosed DM, were excluded from the study. Other exclusion criteria were: 
HIV-positive status, overt liver, renal or thyroid disease and smoking more than 20 
cigarettes per day.   
 
On the first day of the study, each subject underwent a structured examination, which 
included an interview, height, weight and waist measurements, a fasting venipuncture 
and an oral glucose tolerance test. Height and weight were measured to the nearest 0.5 
cm and 0.1 kg respectively. Body mass index was calculated as weight divided by 
height squared. Waist circumference was determined to the nearest 0.1 cm using a 
measuring tape positioned at the midpoint between the lowest rib and the iliac crest.  
 
Questionnaires were used to obtain information about demographic variables, medical 
history, medication use, dietary habits, physical activity and smoking status (see 
Appendix A). On the second occasion, after an overnight fast, the hyperinsulinaemic 
euglycaemia clamp technique was performed. An eight-hour oral fat tolerance test was 
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done on the third visit, after the subject had undergone a 12 hour overnight fast.    All 
participants provided written, informed consent to take part in the study, which was 
approved by the Human Research Ethics Committee of the University of the 
Witwatersrand (see Appendix B).  
  
2.1  SUBJECTS  
 
Black patients attending the Chris Hani Baragwanath Hospital in Soweto, Johannesburg 
Hospital and Helen Joseph Hospital, who had undergone diagnostic coronary 
angiography to confirm or exclude CAD, were approached to participate in the study. 
Forty patients (33 men and 7 women) with documented CAD, agreed to take part.  The 
CAD patients were all attending cardiac clinics in the above-mentioned hospitals. The 
fact that there were more men than women was pure coincidence and not studies bias. 
Patients were chosen on first come, first served basis. Newly diagnosed CAD patients 
were identified and recruited into the study. It just happened that there were more men 
than women admitted for CAD during the study period.  The majority of the study 
patients were recruited from Baragwanath hospital cardiac High Care ward.  Twenty 
control subjects (13 men and 7 women), who were matched with the patients for age, 
Body Mass Index (BMI), Waist Circumference (WC) and waist-to-hip-ratio (WHR) 
were also studied. The control subjects were also cardiac patients with no documented 
history of CAD.  Some of them were admitted for valvular or dilated cardiomyopathy 
related pathologies.  
 
Patients and control subjects were classified according to the number and extent of 
lesions in coronary arteries, which were verified by a coronary angiogram performed in 
the preceding 24 months. All of the patients had significant CAD, which was defined as 
more than 50% lesions in one or more of the major coronary arteries. None of the 
control subjects had evidence of coronary atherosclerosis on coronary angiography. 
Patients who had a previous MI were also at least three months post-MI before the 
study started. The majority of patients (95%) and control subjects (75%) had moderate 
hypertension and they were taking anti-hypertensive medication at the time of the 
study. 
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2.2  EXCLUSION AND INCLUSION CRITERIA  
 
Subjects must have a blood pressure of < 160/100 mm/Hg for inclusion into the study. 
Patients who had a dominant risk factor, such as severe hypercholesterolaemia, defined 
as an untreated total cholesterol of over 7.5 mmol/l, or subjects with clinical features of 
familial hypercholesterolaemia, were excluded from the study. Subjects who had been 
diagnosed previously with diabetes mellitus were excluded from the study.  The 
potential recruits were asked about their past medical history and medications to 
determine if they were diabetic or not.   HIV positive subjects were excluded. Most of 
the subjects were not keen to reveal their HIV status. Hospital records proved useful in 
this regard.   Other exclusion criteria were smoking more than 20 cigarettes per day, 
overt liver, renal or thyroid disease.   
 
All subjects gave written, informed consent to participate in the study, which was 
approved by the Human Research Ethics Committee of the University of the 
Witwatersrand (see Appendix A).  
 
Procedure  
 
Full explanation was given to the study subjects during the recruitment phase. This was 
done in a language preferred by the study subjects.  Those subjects who agreed to 
partake in the study will give a verbal and written consent. Lipid lowering drug therapy 
(statins and fibrates) were stopped 4 weeks prior to testing. Other drugs which may alter 
lipid levels and insulin resistance (e.g. thiazide diuretics, beta-blockers, steroids etc) as 
well as aspirin were stopped 3 days prior to testing.  Following a 12-hour overnight fast, 
subjects had baseline assessments performed followed by an oral glucose tolerance test.  
On the day of the study, each participant underwent a structured exam, which included 
an interview. Height, weight, WC, WHR measurements were done. Height and weight 
were measured to the nearest 0.5 cm and 0.1 kg, respectively.  BMI was calculated as 
weight (kg) divided by height (m) squared. WC was determined to the nearest 0.1 cm 
using a measuring tape positioned at the midpoint between the lowest rib and the iliac 
crest and hips were measured at the largest gluteal circumference.  These measurements 
were used to calculate WHR. Questionnaires were used to obtain information on 
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demographic variables, medical history, medication use, dietary habits physical activity 
and smoking status.  The whole tests will take three weeks to complete.  The first visit 
on week 1 was for the OGTT.  A week later, the subject will return for the eight hourly 
Oral Fat Tolerance Test. the last week was for the insulin clamp.   
 
2.3  METABOLIC STUDIES  
 
2.3.1  Oral glucose tolerance test (OGTT)  
  
A standard OGTT (75g glucose), as described by the WHO, was performed and glucose 
concentrations were measured at baseline and at two hours post-load. IGT and diabetes 
mellitus (DM) were defined according to the criteria adopted by the American Diabetes 
Association (ADA).  
 
Normal glucose tolerance (NGT) was defined as a fasting glucose level of < 5.6 mmol/l 
and a two hour post load glucose level of < 7.8 mmol/l; alternatively a two-hour post-
load glucose concentration of > 7.8mmol/l but < 11.1 mmol/l denotes an Impaired 
Glucose Tolerance (IGT). DM was diagnosed if the fasting plasma glucose value was 
>7.0 mmol/l or the two hour post load glucose value was >11.1 mmol/l.  
 
2.3.2  Oral fat tolerance test (OFTT)  
 
After a 12 hour overnight fast, an intravenous catheter was inserted into a forearm vein 
for blood sampling. The OFTT was performed as described by Patsch et al (76), with a 
slight modification of the fatty meal.  Briefly it consisted of cream, chocolate-flavoured 
syrup, sugar and powdered milk, which provided energy from fat (83.5%), 
carbohydrates (14%) and protein (2.5%). The meal was consumed within 20 minutes, 
after which the participants were instructed not to take anything orally for the next eight 
hours, except for water. Lipid profiles compromising TC, HDL cholesterol, LDL 
cholesterol and TG concentrations were measured at baseline (defined as the value at 
0h) and at 2 h, 4 h, 6 h and 8 h post-load. In addition, fasting levels of Apo A-1, Apo B, 
LP (a), free fatty acids (FFA), glucose and LDL particle sizes were measured.  
 
2.3.4 Hyperinsulinaemic euglcaemic clamp technique  
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There is general agreement that the glucose clamp technique, particularly in its 
euglycaemic version, is the best available standard for the measurement of insulin 
action (how to measure insulin sensitivity). The clamp technique allows for the 
assessment of three important physiological variables.  It provides a measure of the total 
amount of glucose metabolized, the response of the beat-cell can be quantified and the 
early and late phases of insulin secretion examined. (77) Briefly, an intravenous 
catheter was inserted by venipuncture for purposes of the infusion of glucose and 
insulin. A second catheter was inserted into a dorsal hand or wrist vein and the hand 
was enclosed in an electric heat pad, which was warmed to approximately 70 C to 
arterialize the blood obtained for all the samples. Three blood samples were drawn at 
10-minute intervals to assess the basal glucose concentration. Thereafter, the glucose 
concentration was measured and the exogenous 10% dextrose infusion rate was 
adjusted at 10-minute intervals, as calculated by a computerized algorithm based on the 
negative feedback principle. Insulin-mediated glucose disposal was measured at a 
single infusion rate of 40 mU/m2/minutes (Actrapid, Novo Nordisk, Denmark). Blood 
glucose was clamped at 5.1 mmol/l for the next 120 minutes by infusion of 10% 
glucose at various rates, according to blood glucose measurements performed at 10 
minute intervals.  
 
The mean amount of glucose infused during the last 30 minutes was used to determine 
the steady-state glucose requirements. Insulin-mediated glucose disposal (M-value) was 
expressed as mg/kg/min, with a normal value being above 5.0 mg/kg/min and a value 
below this level indicating insulin resistance. A minimal mathematical model of glucose 
kinetics is implemented on a laboratory minicomputer during clamp experiments. (78) 
The computer estimates the fractional disappearance rate of glucose and calculates the 
rate of exogenous infusion required to match the desired concentration (M).  The rate of 
glucose infusion necessary to support the glucose level is an index of the sensitivity of 
overall glucose utilization to insulin.  PACBERG, a new computer program estimates 
the insulin dependent increase in fractional disappearance rate of glucose. (79) In 
addition the program calculates the rate of exogenous glucose infusion, which must be 
infused to maintain the desired glucose concentration.   The clamp technique affords a 
highly reproducible method of assessing beat-cell sensitivity to glucose as well as of 
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quantifying the amounts of glucose metabolized by the body in vivo. hypoglycemic 
reactions are prevented .   
 
2.4 INTIMA-MEDIA THICKNESS  
 
2.4.1  Ultrasound Technique 
 
B-mode ultrasound measurement of the carotid intima-media thickness was carried out 
on all patients as a blind study: the operator was unaware of the outcome of the 
coronary angiography. A standardized ultrasound technique was used, using a Toshiba 
System: Nemio Model SSA-550A. The transducer frequency was set at 11MHz for all 
patients. 
 
Measurements of the intima-media thickness were carried out at the optimum angle of 
interrogation (OAI), which allows visualization of the flow tip divider, the common 
carotid artery (CCA), external carotid artery (ECA) and the internal carotid artery (ICA) 
from a single selected angle of the carotid arteries at the bifurcation. Doppler was used 
to verify the identification of the ECA and ICA. 
 
The IMT was measured when the two echogenic lines, representing the lumen-intima 
interface and the media-adventitia interface, were visualized over a length of ≥1cm. 
Measurements of the IMT were done manually, using the calliper markers of the 
ultrasound unit.  
 
The IMT at the optimal angle of interrogation was measured as the area of maximum 
thickness at the near and far walls of the CCA, BIF and ICA bilaterally (a total of 12 
sites). In cases where calcified plaque obscured the IMT in the bulb, one wall was 
measured; the thickest measurement in each segment was imaged and recorded as the 
final measurement. The mean maximum IMT was recorded as the CIMT. Images were 
stored on a magnetic optical disc as well as on thermal paper. 
 
 
 
20
The CIMT was calculated as the average for 12 sites for all subjects; this was done 
using the Excel programme for Windows XP. Mean values for the CIMT > 0.8mm were 
classified as increased thickness. 
 
2.5  STATISTICAL ANALYSIS  
  
Data analysis was performed using the GB-STAT program (Dynamic Microsystems, 
Inc, Silver Spring, MD, USA), with a value of P< 0.05 considered significant. One way 
analysis of variance (ANOVA) for repeated measures within a group or ANOVA for 
completely randomized measures between groups was used to assess any differences 
between the means of the variables, as appropriate. Comparison of two groups was 
done by the Student’s paired or unpaired t-test, and the Mann-Whitney U-test or the 
Wilcoxon Signed-Rank test for parametric or non-parametric data, respectively. Results 
are expressed as mean +/- SD or as proportion (%).  The frequency of M-values above 
and below the normal level was compared using Fishers Exact test. Area under the 
curve (AUC) for serial measurements of glucose, insulin and proinsulin concentrations 
at 0 minutes and after the glucose load was calculated using the trapezoid rule. Linear 
regression analysis and correlation coefficient calculations were performed to reveal 
any significant determinants of postprandial hyperglycaemia.          
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CHAPTER 3:   MANUSCRIPTS   
 
 
3.1  MANUSCRIPT 1  
 
(In print – Ntyintyane, L.M., Panz, V.R., Raal, F.J. and Gill, G.V. The metabolic 
syndrome using the National Cholesterol Education Program and International Diabetes 
Federation definitions among urbanized Black coronary artery disease. Journal of 
Endocrinology, Metabolism and Diabetes of South Africa, Vol 12(1) 2007:6-12.  
 
The manuscript is attached as Annexure C. 
 
3.2  MANUSCRIPT 2 
 
(In print – Ntyintyane, L.M., Panz, V.R., Raal, F.J and Gill, G.V. Metabolic syndrome, 
undiagnosed diabetes mellitus and insulin resistance are highly prevalent in urbanized 
South African Blacks with coronary artery disease. Cardiovascular Journal of South 
Africa 2006; 17:7-12.  
 
The manuscript is attached as Annexure D. 
 
3.3  MANUSCRIPT 3  
 
(In print – Ntyintyane, L.M., Panz, V.R., Raal, F.J. and Gill, G.V. Postprandial 
lipaemia, metabolic syndrome and LDL particle size in urbanised South African Blacks 
with and without coronary artery disease.  Q J Med 2008:101; 111-119.    
 
The manuscript is attached as Annexure E. 
 
3.4     MANUSCRIPT 4  
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(In print – Ntyintyane L, Panz V, Raal F, Gill G. Postprandial hyperglycemia in urban 
South African Blacks with and without coronary artery disease. Metabolic Syndrome 
and Related Disorders 2008) 
Title: POSTPRANDIAL HYPERGLYCAEMIA IN URBANISED SOUTH 
AFRICANS WITH AND WITHOUT CORONARY ARTERY DISEASE 
 
The manuscript is attached as Annexure F. 
 
3.5 MANUSCRIPT 5  
 
(Accepted for publication - Cardiovascular Journal of Africa)  
 
Title: CAROTID INTIMA-MEDIA THICKNESS IS A PREDICTOR OF 
CORONARY ARTERY DISEASE IN SOUTH AFRICAN BLACK PATIENTS.  
 
A copy of the full manuscript is attached as Annexure G. 
 
3.6 MANUSCRIPT 6  
 
(Accepted for publication – Metabolic Syndrome and Related Disorders) 
 
Title: LEPTIN, ADIPONECTIN AND HS-CRP IN RELATION TO THE 
METABOLIC SYNDROME IN URBAN SOUTH AFRICANS WITH AND 
WITHOUT CORONARY ARTERY DISEASE (CAD).   
 
A copy of the full manuscript is attached as Annexure H. 
 
3.7   MANUSCRIPT 7   
 
MANUSCRIPT IN PREPARATION  
 
(Preparation for submission to The South African Journal of Clinical Nutrition)  
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Title: DIETARY INTAKE, SOCIO-DEMOGRAPHICS AND PHYSICAL ACTIVITY 
OF A BLACK URBANISED SOUTH AFRICAN POPULATION WITH CORONARY 
ARTERY DISEASE COMPARED TO HEALTHY VOLUNTEERS. 
 
The manuscript is attached as Annexure I. 
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S. Spectrum of heart disease and risk factors in a black urban population in South 
Africa (the Heart of Soweto Study): a cohort study. Lancet 2008; 371:915-922.   
 
2.  Ntyintyane, L.M. Metabolic Syndrome: Fact or Fiction. SA Cardiology and 
Stroke Journal, Summer 2008; 2:37-44.  
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CHAPTER 4:    DISCUSSION OF MAJOR FINDINGS  
 
 
4.1  METABOLIC SYNDROME   
 
The series of papers on MS show that black South African patients with CAD have a 
high risk of MS. Abdominal obesity measured as waist circumference was the most 
important risk factor for the syndrome and, together with hypertension and elevated 
glucose concentrations, formed the most frequent risk factor combination.  
 
Obesity and insulin resistance are significant, interrelated causes of MS. Previously 
undiagnosed IGT and DM were common abnormalities. The study highlights the 
clinical relevance of MS, its likely impact on the morbidity and mortality and that its 
identification is, therefore, important in risk assessment of patients with CAD. The 
investigations showed, in addition, that the two definitions of metabolic syndrome i.e. 
new IDF criteria and the older NECP: ATPIII, similarly identified the presence or 
absence of the MS in 83% of the patients. That both definitions generated similar 
prevalence estimates of MS implies that the predicted risk of developing CAD, DM and 
other adverse events, based on the new IDF definitions, is likely to be similar to that 
observed with the NECP: ATPIII definition. Regardless of which definition is used, the 
high prevalence rate indicates that large numbers of black South Africans with CAD are 
likely to have MS. 
  
Can we then extrapolate from these findings, that metabolic syndrome; is a better 
diagnostic screening tool for cardiovascular disease and diabetes?   Secondly, do we 
need another syndrome?  These two central issues underline the current debate on the 
clinical relevance of metabolic syndrome.     
 
A school of thought believes metabolic syndrome is an invention of the pharmaceutical 
industry that is being rushed through.  There is much fundamental, clinically important 
and critically missing information that warrant a more serious examination of whether 
medical science is doing any good by drawing attention to and presumed disease that 
does not stand on firm ground. (80) Such issues as follows: are all risk factors equally 
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important?  Is the syndrome better than the Framingham risk score in cardiovascular 
disease screening?  What is the underlying pathology?  
 
P Zimmet and George Alberti the leading proponents in this regard, hold the opposing 
view that:  “recognizing the syndrome provides a simple public health strategy to define 
those at high risk”.  (81) Lack of clear pathophysiology, is not an excuse to disregard its 
clinical importance.  Although the aetiology of the syndrome remains uncertain, strong 
hypotheses implicate central adiposity, insulin resistance and low-grade inflammation. 
The syndrome is not intended to give an absolute risk of cardiovascular disease or 
diabetes but to highlight people at increased relative risk on whom doctors can then 
focus. In the Prospective Study of Pravastatin in the elderly at Risk (PROSPER), 
metabolic syndrome was not associated with increased risk of cardiovascular disease in 
those without baseline disease, but was associated with increased of diabetes. (82) In 
the 10-year Hoorn study, the metabolic syndrome, however defined, is associated with 
an approximate 2-fold increased risk of incident cardiovascular morbidity and mortality 
in a European population. (83) In conclusion, metabolic syndrome is not a substitute for 
the Framingham, but to complement it.   Nonetheless, more research needs to be done 
on this area. Because prevalence of obesity and the metabolic syndrome is rapidly 
increasing in developing countries, leading to increased morbidity and mortality due to 
type two diabetes mellitus and cardiovascular disease. (84)      
 
4.2  POSTPRANDIAL GLUCOSE  
 
Worldwide, the number of people with prediabetes estimated at 314 million and 
projected at 418 million by 2015. (85) As the prevalence of and progression to diabetes 
continue to increase, diabetes related morbidity and mortality have emerged as major 
public health care issues.  Abnormal glucose tolerance is almost twice as common 
amongst patients with a myocardial infarction.  Little has been done on postprandial 
state in urbanized black patients with CAD, i.e. the period that compromises and 
follows a meal.  It was hypothesized that postprandial hyperglycaemia is a CAD risk 
factor.  
 
The study showed that postprandial hyperglycaemia is common in black South African 
CAD patients. Postprandial hyperglycaemia is determined by many factors, including 
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the timing, quantity and composition of a meal. High-calorie foods that are rich in 
refined carbohydrates can cause an exaggerated increase in blood glucose,  
Which is repeated many times each day?   
 
Recognition is growing that hypergylcaemia, and specifically postprandial 
hyperglycaemia, is a clinically significant risk factor for the development of coronary 
artery disease.  The research results showed that glucose AUC was significantly higher 
in the patients than in control subjects at both 0 minutes and 120 minutes.  The precise 
mechanisms through which postprandial hyperglycaemia exerts its adverse effects have 
not yet been fully elucidated, but some putative cause-effect interactions have.   
 
Importantly, the time courses of postprandial hypergylcaemia and postprandial lipaemia 
are different: postprandial hypergylcaemia is typically an early phenomenon, followed 
by a prolonged period of postprandial lipaemia.  Both processes, however, induce 
oxidative stress, which may cause endothelial dysfunction and which promotes the 
development of CAD.      
 
4.3   POSTPRANDIAL LIPAEMIA 
 
The causal role of an elevated serum cholesterol level in the genesis of atherosclerosis 
and its clinical sequelae, particularly ischemic heart disease, is now well established. 
(86) Angiographic studies have also demonstrated a positive relation between the 
presence of coronary artery disease and serum levels of total cholesterol, LDL 
cholesterol, and apolipoprotein B. Much of our knowledge about the relationship 
between lipid and lipoprotein metabolism and development of atherosclerosis and 
cardiovascular disease is based on measurements in the fasting state. (87) There are 
several lines of evidence suggesting that postprandial lipemia increases risk of 
atherogenesis.  As far as is known, this is the first study to contribute to the information 
about postprandial lipaemia in urbanized South Africans with CAD.   
 
Our results show a correlation between postprandial lipemia and the presence of 
coronary artery disease in urbanized South Africans. The CAD patients with and 
without metabolic syndrome had similar fasting lipid profiles. However, the fasting TG 
concentration was the strongest determinant of postprandial lipaemia. Small, dense 
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LDL particles were present in more than 70% of the patients with CAD. Fasting lipid 
profiles and postprandial responses to the oral fat load were similar in patients with and 
without metabolic syndrome.  
 
There was a consistent relationship between increased fasting TG concentrations, 
elevated postprandial TG and the presence of small, dense LDL particles. Prolonged 
exposure of the endothelium to the TG-rich atherogenic remnant particles might be the 
reason why postprandial increases in TG account for greater CAD risk. In a study by 
Patsch et al (88), on an Austrian cohort, demonstrated the association between late 
postprandial triglyceride levels and CAD. Is the postprandial lipemia a better surrogate 
marker of ischemic heart disease than Apo B?  The Swedish prospective study 
AMORIS, found Apo B to be a stronger marker of CVD risk than LDL cholesterol. 
(89). The INTERHEART study used the ApoB/Apo A-1 ratio. The only constraint for 
using ApoB is finance especially within the African context. It is very expensive. In the 
future, more studies are needed to compare the reliability and sensitivity of postprandial 
lipemia and Apo B.  
 
4.4   EPIDEMIOLOGICAL TRANSITION  
 
An epidemiological transition is now occurring in the developing world: the major 
causes of death are changing from infectious diseases to non-communicable diseases 
such as coronary heart disease (see Table 3 below). Urbanization, industrialization and 
socio-economic development have resulted in significant changes in lifestyles. The 
WHO has estimated that by 2020, one third of the global burden of disease will be 
attributed to non-communicable diseases.  
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Table 3:  Epidemiological transition 
Modified Model of the Stages of Epidemiologic Transition as it Pertains to Cardiovascular Diseases
Yusuf et al   Global Burden of Cardiovascular Diseases, Part 1   2749
(Circulation. 2001;104:2746-2753)
Stages of Development
Deaths From CVD,
% of Total Deaths Predominant CVD and Risk Factors Regional Examples
Age of pestilence and famine
Age of receding pendemics
Age of degenerative and 
man-made diseases
Age of delayed degenerative 
diseases
Rheumatic heart disease, infections and nutritional 
cardiomyopathies
As above +hypertensive heart disease and hemorrhagic strokes 
All forms of stroke, ischemic heart disease at young ages, 
increasing obesity and diabetes
Stroke and ischemic heart disease at old age
Re-emergence of deaths from rheumatic heart disease, 
infections, increased alcoholism and violence; increase in 
ischemic and hypertensive diseases in the young
During Stages 1 to 4, l ife expectance increases, whereas in Stage 5 life expectancy decreases compared with stages 4 and even 3.
Age of health regression and
social unheaval
5-10
4
5
1
2
3
10-35
35-65
<50
35-55
Sub-Saharan Africa, rural India,
South America
China
Urban India, former socialist
economies, aboriginal
communities
Western Europe, North America
Australia, New Zealand
Russia
Chronic diseases of lifestyle are a group of diseases that share similar risk factors 
because of exposure, over many decades, to unhealthy diets, smoking, and a lack of 
exercise and possibly stress. People are moving from the traditional healthy ways of 
living and are increasingly adopting unhealthy lifestyle practices. Shifts in dietary 
intake and physical activity patterns to higher fat intake and inactivity are contributing 
factors.  The globalization of food production and marketing is also contributing to the 
increasing consumption of energy dense foods poor in dietary fibre and several 
micronutrients. It has been the historical experience of the developed countries that the 
cardiovascular the epidemic usually commences in members of the higher social classes 
- later the risk permeates across the social spectrum. 
 
A school of thought believes epidemiological transition is misplaced in Africa. (90) 
They are of the view that infectious diseases should be Africa’s public health priority. I 
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disagree. It would be negligent and dangerous to ignore the socio-economic risks posed 
by cardiovascular diseases. South Africa is not immune to epidemiological transition 
just like any other developing country.  China has experienced an epidemiological 
transition shifting from the infectious to the chronic diseases. (91) China already has 
177 million adults with hypertension; furthermore, 303 million adults smoke, which is a 
third of the world’s total number of smokers. 
 
The Interheart Africa study showed that developing countries are undergoing 
globalization and epidemiological transition. The data confirms that people from Africa, 
who are exposed to these known major CVD risk factors, are at risk of developing 
AMI, as are other people across the globe.  Three are only five common risk factors that 
account for 89.2% of the Acute Myocardial Infarction (AMI), i.e.: current /former 
tobacco smoking, hypertension, diabetes, abdominal obesity and lipoprotein 
apoB/apoA1 ratio.   
 
The strong influence also showed that one risk factor is markedly modified by other risk 
factors.   Rapid urbanization of the black population in Soweto places it at risk for 
several diseases.    Soweto, an acronym for South Western Townships, with an 
estimated population of 1.1 million, has one of the largest urban populations of black 
Africans on the African continent. It accommodates black people migrating from rural 
areas.     
 
Rapid transition is expected with an increase in the burden of cardiovascular disease.  
Many black people in urban South Africa have hypertension related to high salt intake, 
have adopted diets similar to those in western countries and have changed to a 
sedentary lifestyle. Even rural black people in South Africa have a CVD risk profile 
that predisposes them to the emergence of atherosclerosis and related chronic diseases. 
(92) The ongoing Heart of Soweto study will provide important insights into the 
prevalence of heart disease in the future.  
 
4.5  CAROTID INTIMA-MEDIA THICKNESS AND CAD  
 
The study findings support the hypothesis, that CIMT is a predictor of coronary artery 
disease in South African black patients. (93) The study group consisted of patients 
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admitted with angiographically confirmed coronary artery disease.  The majority of 
patients were on treatment for hypertension.  Diabetes and HIV positive patients 
excluded from the study, due to their high risk of vascular disease.    
 
The thickness of the intima-media complex increases with age, hypertension, diabetes 
mellitus and hyperlipidaemia.  The intima-media thickness was more pronounced in 
obese patients and those with abnormal fasting glucose levels. Bearing in mind that 
diabetics were excluded from the study, the effect of high fasting blood glucose levels 
on the CIMT was significant.  
 
There was a good correlation of CIMT against fasting blood glucose levels of the whole 
group in simple linear regression analysis (r= 0.35; P=0.03). In addition, 100% of 
subjects with high fasting blood glucose had an increased CIMT.  
 
The median percentile scores show a progressive increase as the number of vessels 
involved increases.  The average IMT for the control subjects was lower than in CAD 
cases. In three vessel diseases, the IMT average was 1.29 mm.  
 
In the study done by Kablak-Ziembicka et al (94), showed that increased CIMT was 
positively and linearly related to CIMT: subjects with a greater number of vessels 
involved showed greater increases in CIMT. In addition, they showed that a CIMT over 
1.15mm was predictive of a 94% likelihood of having CAD. The study by Geroulakos 
et al (95), showed that there was a significant positive linear trend between CIMT and 
the number of involved vessels (p<0.0001, r=0.44). It demonstrated a high positive 
predictive value and specificity for the presence of CAD, if a corrected-for-age CIMT 
>0.85 mm is used as a cut-off point for the prediction of severe CAD.  
 
The findings in the study support previous studies, where increased CIMT was 
correlated with evidence of angiographically proven CAD. (96) CIMT could be useful 
as a screening tool in a population with a low prevalence of CAD. (97)  
 
4.6    INFLAMMATION, METABOLIC SYNDROME AND CAD    
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Recent research has shown that inflammation plays a key role in coronary artery disease 
and other manifestation of atherosclerosis. (98) Elevated levels of inflammatory 
markers, particularly C-reactive protein, indicate an increased risk of coronary heart 
disease (99) the study assessed the integrated relationship between MS, obesity and 
inflammation in urban South African black patients with CAD, some of whom also had 
MS. The major findings were that, of the three markers, only leptin was significantly 
higher in patients with MS compared to patients without MS. Leptin levels in both 
women and men with MS were significantly higher than in those without MS.  The 
higher leptin levels measured in the patients with MS reflected their greater degree of 
body fat mass and abdominal obesity compared to those without MS.   
 
Previous studies as well as this study’s contribution to a report on body composition, 
have stated that BMI and WC are important determinants of increased leptin levels. 
Positive correlations between leptin and hs-CRP, as well as hs-CRP and BMI suggested 
that these markers were closely related to obesity and inflammation in the CAD 
patients.  
 
The study was limited by the relatively small groups of patients and control subjects 
and by the low number of patients who fulfilled all five criteria for the MS.  It was 
concluded that leptin, in addition to being an indicator of obesity, was also a useful 
marker of inflammation in our CAD patients.  
  
4.7  NUTRITION AND CAD   
 
The study investigated the role of diet, socio-demographics and physical activity in a 
black South African population with CAD compared to a healthy control group. No 
differences were found between the dietary intake, physical activity or socio-
demographics of the two groups, except for vitamin C intake (p=0.049), with the 
controls having a median vitamin C intake within the DRI range (94mg) and the CAD 
patients an intake well below (47mg).  Compared to dietary guidelines for the 
prevention of CAD, saturated fatty acid and cholesterol intake were above the 
recommended intake and fibre, folate and vitamin E were all below the recommended 
intake for both groups.   
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In order to determine the role of urbanisation on diet, the study population’s diet was 
compared to that of a traditional rural group and an urban group with a comparable 
socio-demographic status. The study population’s diet found to be westernized 
compared to both the rural and urban group. 
 
In conclusion, when the confounding factors of age and obesity were accounted for, 
there were no differences in the diet, physical activity or socio-demographics of the 
CAD patients and the control group, except for vitamin C intake; both groups had a 
micro-nutrient intake below the recommended level.  While diet is affected by 
urbanisation, differences in dietary intake were observed between the two urban groups, 
regardless of the similarity in their socio-demographic profile. 
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CHAPTER 5:    STUDY LIMITATIONS  
 
 
The relatively small number of patients studied, particularly the low number of women, 
hampered a wider extrapolation of the study results. The findings should, therefore, be 
considered as somewhat preliminary, awaiting confirmation in a larger study. The 
strengths of the study include a detailed assessment of MS risk factors and the exclusion 
of confounding variables (such as diabetes mellitus and severe hypercholesterolemia) 
from the patient cohort.  
 
An additional limiting factor was that the criteria for postprandial TG levels, similar to 
the diagnostic glucose tolerance test, have not been specified for the OFTT. This lack of 
standardization made it difficult to compare studies because researchers have used 
different meals containing variable amounts of fat, carbohydrate and protein.  
 
Furthermore, the length of all studies was not uniform. Some studies measured TG 
concentration every hour; others took measurements every two hours.  
 
This is also the first study on postprandial lipaemia in urbanized South Africans with 
CAD.   
 
The study also highlighted the clinical relevance of MS, its likely impact on morbidity 
and mortality and that its identification is, therefore, important in risk assessment of 
patients with CAD.   
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CHAPTER 6:   GAPS IN OUR KNOWLEDGE  
 
 
CVD and its major component, heart disease, exists in epidemic proportions in 
Western, developed countries. The causes and consequences of an epidemic of CVD, in 
the Western world have been comprehensively documented. In contrast, there is a 
paucity of data to describe the emergence and impact of CVD in low to middle-income 
countries.   
 
Historically, the black population was perceived to be immune to coronary artery 
disease. However, the emergence of a range of modifiable risk factors, including 
smoking, obesity, hypertension and hyperlipidemia in the context of historically low 
rates of CAD, has major public health implications. Africa faces the emergence of 
chronic diseases, including cardiovascular diseases, diabetes and cancers.  The overall 
burden of CVD is predicted to rise by approximately 150% in the developing world 
within the next 20 years. In Africa alone, it is predicted CVD will affect 1.3 million 
people per annum during this period.  
 
With industrialization, the major causes of death have shifted from infectious and 
nutritional deficiencies to disorders that are more chronic: a phenomenon known as 
epidemiologic transition. It is, therefore, imperative to expedite CVD studies in Africa 
to improve the understanding of the risk factor profile of this emerging epidemic in the 
black population. Other institutions will copy the Heart of Soweto cardiovascular 
disease registry, at CHBH in Soweto.   
 
The paucity of data on CVD is a serious shortcoming that needs to be corrected 
urgently due to its danger to the economic growth of the country.  Anecdotal reports put 
the cardiovascular disease economic burden at 2% - 3% of gross domestic product 
(GPD).  
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CHAPTER 7:   FUTURE STUDIES  
 
 
South Africa is facing a triple burden from infectious diseases, chronic diseases of 
lifestyle and trauma. Improved socio-economic conditions meant decreased physical 
activity and an increased intake of saturated fats, smoking and chronic disease of 
lifestyle. The increasing global burden of CVD needs to be addressed.  Intervention to 
prevent morbidity and mortality from chronic diseases need to be cost effective and 
financially feasible in countries of low or middle income. (100)  
 
CVD is a major public health challenge, especially for low income and middle-income 
countries, where 80% of these deaths occur. (101) Treatment is likely to account for an 
increasing proportion of health-care expenditure in these countries. (102) For successful 
prevention and control of cardiovascular disease, the present distribution of risk factors 
be reduced. Financial and time constraints make it difficult to conduct long-term cohort 
studies. Public health action cannot afford to wait that long to initiate interventions.    
 
Proven cost effective strategies are available for reducing exposure to chronic disease 
risk factors in low-income and middle –income settings.  Modification of risk factors 
reduces the mortality and morbidity in people with diagnosed and undiagnosed CVD. 
Effective and inexpensive treatments are under-used in developing countries, even in 
secondary prevention this despite proven benefits.  A combination of individual 
prevention approach and population level intervention, based on opportunistic 
screening, identification of high-risk individuals by easily measurable risk factors, and 
treatment with a multi-drug regimen, could avert some CVD.   
 
The paucity of data on cardiovascular diseases in South Africa, however, limits any 
effective intervention strategies. Scaling up this intervention is essential for achieving 
the goal of yearly reduction in rates of chronic disease deaths in the future. The WHO 
Comparative Risk Assessment project estimated the number of deaths from chronic 
diseases is averted if the distributions of major risk factors were reduced: worldwide, 
millions of deaths could be averted if the selected measures to reduce tobacco and salt 
exposure were implemented.  
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A shift from the management of single risk factors to total cardiovascular risk 
prediction and management will enable health resources to be targeted at individuals 
who are most in need and most likely to benefit.    
 
Financial cost estimates regarding cardiovascular disease in South Africa is required.   
The impact of HIV/AIDS on cardiovascular diseases needs to be studied further.  The 
expected epidemiological transition in sub-Saharan Africa is being radically altered by 
the HIV/AIDS pandemic, and the drastically shortened life expectancy in the region 
means that the age structure is skewed to those who are younger.  
 
Certain areas of CVD epidemiology need special attention in the studies. Nutritional 
epidemiology in diverse cultural settings with widely varying dietary practices faces the 
challenge of identifying affordable and culturally acceptable diets for each population. 
Food labeling is critical in empowering consumers by providing the necessary dietary 
information.  Culturally appropriate dietary studies are needed as part of a patient’s 
education.  Cultural beliefs are more important in influencing consumers’ food choices.   
 
Political action is needed to reverse the negative trends of obesity and sedentary habits, 
ranging from fighting against the fast food and sugar industries to safe bicycle paths and 
healthy school meals. ((103) Health policy research be strengthened. The existing 
health care infrastructure is equipped to handle mostly the pre-transitional agenda of 
infectious and nutritional deficiency disorders. Health education is a priority. Public 
health action for CVD in the developing countries linked to a policy-relevant research 
agenda. Advancement of global cardiovascular disease prevention needs strong 
international leadership. (104)  
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CHAPTER 8:  RECOMMENDATIONS  
 
 
In the book, “Fat Land – how Americans became the fattest people in the world”, Greg 
Critser writes: “…in the twenty-first century, we have put ourselves in the first circle of 
fat hell. How we get out of that hell depends not upon prayer, but rather upon a new 
sense of collective will - and individual willpower”.  It is willpower combined with 
collective effort from the individual to the state. Successful intervention will require a 
holistic approach from all major stakeholders, i.e. the policy makers, business sector, 
health care industry, civil society and different communities.  
 
8.1  SHORT TO MEDIUM TERM  
 
8.1.1   Government 
 
Central government should play an active role in promoting a healthy lifestyle.   State 
officials should be part of CVD awareness campaigns, such as the September Heart 
Awareness Month.  This will go a long way to changing existing perceptions and 
stereotypes about CVD.  
 
8.1. 2  Schools  
 
A healthy lifestyle should start at pre-school level.  Fitness projects such as Health of 
the Nation, organized by Sporting Chance and Virgin Active, deserve support that is 
more public.  Bring back the physical training period at schools. Lastly, every school 
should have a dietician.    
 
8.1.3  Dieticians  
 
There is a serious shortage of dieticians in the country.  A 3000-bed hospital, such as 
CHBH, has less than 10 dieticians. Something is wrong here.  Some areas in Soweto 
have never seen a dietician.  
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A leading Sunday newspaper reported on a study by the University of the 
Witwatersrand (Sunday Times, 12 October 2008). It found teenagers in Soweto eat 
more fatty and salty food than children in the USA. This is due to a lack of knowledge 
and ignorance amongst the youngsters about correct eating habits. Hence, the high 
levels of overweight and obesity in the townships.   
 
It is in the interests of the country to make the profession more attractive and 
economically viable.  
 
8.1.4  Media  
 
The BBC’s Fat Challenge campaign illustrates the power of the media in changing 
behaviour.  The aim of the Fat Challenge is to encourage citizens to adopt an active 
lifestyle.  South African media can emulate this example by being part of the solution to 
the obesity epidemic.  
 
8.2  LONG TERM   
 
8.2.1  Health policies for a healthy lifestyle  
 
The ban on junk food adverts at schools tuck shops is a step in the right direction. The 
amendment of the Foodstuffs, Cosmetics and Disinfectant Act of 1972, is a bold move 
by the state. The draft regulations include mandatory markings on most foodstuffs and 
new food labeling. This will allow customers to make informed choices about the food 
they are buying.  More policies of this nature are needed to encourage a healthy 
lifestyle.  
 
8.2.2 Primary health care  
 
Disease prevention is a primary care responsibility. Currently, the country’s clinics are 
not functioning well. Many patients have no confidence in the services provided.  
Clinics are under-staffed and demoralized.  It is critical that these structures are 
functioning.  
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Secondly, there is a need to train more health educators.  These foot doctors promote 
disease prevention.  Many unemployed graduates can assist in this task.  
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CHAPTER 9:    CONCLUSION 
 
 
It is postulated that, by 2025, CVD will overtake HIV/AIDS as the leading cause of 
death in Africa.  The post-apartheid period has witnessed massive economic growth, 
urbanization, improved sanitation and better access to clean water.  Higher disposable 
income within the black communities has led to increased sedentary lifestyles 
characterized by a lack of exercise and an increase in smoking and Westernization of 
diet.   
 
Epidemiological transition is a common feature of the developing economies 
worldwide. This thesis is the first step in addressing the biochemical genesis of this 
transition within the black population. This is the first work of this kind in South Africa 
to study the relationship between epidemiological transition, metabolic risk factors and 
CAD prevalence within the black population.    
 
In concluding, it is appropriate to recap the main hypotheses and how were these 
answered.  
 
In papers 1 and 2 it was demonstrated that MS, undiagnosed diabetes mellitus and 
insulin resistance are highly prevalent in urbanized South Africans with CAD.  Obesity-
driven diabetes is an important risk factor in CAD.  
 
Papers 3 and 4 showed there is a difference in the biochemical risk factor profile of 
black subjects with CAD, compared to age matched black controls without CAD.  
Secondly, there is a postprandial glucose difference in the black CAD subjects 
compared to age matched controls without CAD.  Lastly, there are postprandial lipids 
differences in lipids and lipoproteins of black CAD subjects compared to age matched 
controls without CAD.    
 
Paper 5 demonstrated the importance of Carotid intima-media thickness as a surrogate 
marker of atherosclerosis.    
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Paper 6, clearly demonstrated that leptin differentiated between CAD patients with and 
without metabolic syndrome and determined MS status in women and men.  
 
In paper 7, there was not much difference between the results of the CAD cases and 
control subjects.    
 
In the event of an increasing HIV/AIDS epidemic in sub-Saharan Africa, it is important 
to fully explore the role of inflammation in the genesis of CAD. More epidemiological 
studies are needed on the nutritional transition within black communities and the use of 
CIMT as a screening tool.  Government must lead the fight against the emerging CVD 
threat.  Investing in CVD research and promoting intervention studies is the first step in 
the right direction.  
 
The socio-economic implications posed by CVD cannot be ignored.  Action must be 
taken –NOW! In the words of Olusegun Obesanjo, the former president of Nigeria: 
“…we cannot afford to say …we must tackle other diseases first - HIV/aids, malaria, 
tuberculosis – then we will deal with chronic diseases. If we wait even 10 years, we will 
find that the problem is even larger and more expensive to address.” 
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APPENDIX A 
 
 
CORONARY ARTERY DISEASE IN THE EMERGING BLACK POPULATION OF 
SOUTH AFRICA – IS THERE ETHNIC IMMUNITY? 
 
Subject Information and Consent Form (Controls) 
 
I am a doctor working in the Department of Medicine at the Johannesburg Hospital. 
 
You have recently had an angiogram of the arteries supplying your heart. You showed 
no evidence of obstruction or narrowing in those arteries. In other words you have no 
evidence of coronary artery disease. 
 
You have a normal or only mildly elevated blood cholesterol level. Yet some people 
with a similar cholesterol level develop coronary artery disease. My colleagues and I 
aim to determine whether those who develop coronary artery disease have higher levels 
of cholesterol and/or glucose in your blood after eating than people who do not have 
coronary artery disease. 
 
We would like you to participate in this study. 
 
The study involves three tests that will be done on three separate occasions. 
 
Test 1.  Oral glucose Tolerance Test 
 
You will be asked to fast, only to drink water from 20h00 on the night before the test. 
At 8h00 the next morning (day of the test) we will take some blood samples and then 
ask you to drink 75gm. (a teacup) of glucose (sugar). Thereafter we will take a few 
tubes of blood from you at half hourly intervals for 2 hours. This test will be completed 
by 10h00. The total amount of blood that will be taken will be approximately 80 ml (1/3 
cup). We will also ask you to provide us with a urine sample. 
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Test 2.  Oral Fat Tolerance Test 
 
You will be asked to fast, only to drink water, from 20h00 on the night before the test. 
At 08h00 you will be asked to drink 350mls chocolate or strawberry flavoured fat drink 
(the drink is made up of cream, chocolate or strawberry flavoured syrup, sugar and 
powdered milk). Thereafter we will take a few tubes of blood from you at two hourly 
intervals up until 16h00. The total amount of blood that will be taken will be 
approximately 70 ml (1/3 cup). We will also ask you to provide us with another urine 
sample. 
 
Test 3.  Euglycaemic Clamp 
 
This is the final test. You will again be asked to fast. A small cannula (needle) will be 
inserted into a vein in your arm and a small amount of insulin and glucose will be run 
into your vein. Blood samples will be taken frequently from the cannula (needle) in 
your arm. This test aims to assess how sensitive you are to insulin and will last 
approximately three hours. The total amount of blood that will be taken will be 
approximately 50 ml (¼ cup). We will also ask you to provide us with another urine 
sample. 
 
The total amount of blood from all three tests combined will be approximately 200 ml 
(less than 1 cup). 
 
You will be constantly supervised by medical personnel during all the above tests. All 
three procedures are safe and you are unlikely to come to any harm. There may 
however be some pain and discomfort at the site at which we take the blood samples. 
Nausea may be experienced after swallowing the glucose (sugar) or fat meal, but this 
also is unlikely.  
  
You will also be questioned by a dietician about your regular diet and will be 
questioned about your level of physical activity. This will take approximately 30 
minutes. 
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From this study we hope to understand better why people with average fasting 
cholesterol levels can still get coronary artery disease. With a better understanding of 
the cause, we will hopefully be able to prevent coronary artery disease more effectively 
in the future. 
 
Participation in this study is voluntary and you are free to refuse to participate or to 
withdraw your consent at any time. Such refusal will not affect your regular treatments 
or medical care in any way.  In the study, you will be identified by a study number only. 
Your results will therefore remain confidential and will not be disclosed to anyone 
without your approval. 
 
If you have any questions or concerns about the study at any time you can contact 
either Srs. Nancy Holden or Nomsa Ramela in the Department of Chemical 
Pathology Day Ward at 489-8495 or Doctor Lucas Ntyintyane at 488-3818 or 
Professor Derick Raal at 488-3538. 
 
I have fully explained the procedures and have explained the purposes of the study. I 
have asked whether or not any questions have arisen regarding the procedure and have 
answered these questions to the best of my ability. 
 
 
 
Date: ……………………………  Doctor: ……………………………. 
 
 
I have been fully informed as to the procedures to be followed, and have been given 
description of the attendant discomforts, risks and benefits to be expected. In signing 
this consent form I agree to participate in the study and understand that I am free to 
refuse to participate or to withdraw my consent at any time. I understand also that if I 
have any questions at any time, they will be answered. 
 
 
 
Date: ……………………………  Subject: …………………………………. 
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SUBJECT QUESTIONNAIRE 
 
 
Subject number  Hospital No  
Name  Contact No: 
Date   
Gender   
Date of birth  Age  
 
First Language 
Second language 
 
CASE   CONTROL   
 
Date of coronary angiography: 
Findings: 
 
 
 
 
What is your marital status? Never married 1 
 Married 2 
 Divorced 3 
 Widower 4 
   
What is your highest qualification? None 1 
 < Std. 6 2 
 Std. 6-8 3 
 Std. 6-8 + trade 4 
 Std. 9-10 5 
 Std. 9-10 + trade 6 
 Std. 9-10 + academic 7 
 
What is your occupation?  
 
Do you have a job at the moment? Yes 1 
 No 2 
If yes – what kind of job? 
On which days of the week do you work? Irregular (piece work) 1 
 Part time (1-4 days) 2 
 Full time (5-6 days) 3 
 
How much money do you earn per month? R0-100 1 
Is it between R101-500 2 
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 R501-1000 3 
 R1000-2000 4 
 R2000-3000 5 
 R3000+ 6 
 
 
Do you receive any additional pensions? Yes 1 
 No 2 
 
 
How much pension do you receive per month?  
Interviewer - 
Re-evaluate final income category 
 
R0-100 
 
1 
 R101-500 2 
 R501-1000 3 
 R1000-2000 4 
 R2000-3000 5 
 R3000+ 6 
   
Does anybody else contribute money to your household?   Yes 1 
  No 2 
If yes, how much?   
 
Does anybody else contribute other resources e.g. food, 
to your household?  
  
Yes 
 
1 
  No 2 
If yes, describe. 
 
 
How many people eat in your house?    
Children   1 
Adults   2 
What type of house do you live in? Traditional 1 
 Mokuku 2 
 Brick house 3 
 Other 4 
If other, specify   
 
 
Where do you get your drinking water from? Fountain, river 1 
 Communal tap 2 
 Tap on premises 3 
 Tap in house 4 
 Other 5 
If other specify  
Do you have access to electricity inside your house? Yes 1 
 No 2 
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What type of stove do you have? None 1 
 Coal/wood 2 
 Gas or paraffin 3 
 Electric 4 
 
 
What type of fridge do you have? None 1 
 Paraffin 2 
 Gas 3 
 Electric 4 
 
How long have you been living here?  (years)  
 
Where did you live before coming here? Rural area 1 
 Farm 2 
 Squatter camp 3 
 Township 4 
 
RISK FACTORS FOR CORONARY ARTERY DISEASE 
Family history of CAD YES NO  
In whom 
 
Family history of elevated cholesterol YES NO  
In whom 
 
 
Do you snuff? Yes 1 
 No 2 
Do you smoke? Yes 1 
 No 2 
If no – have you smoked regularly before? Yes 1 
 No 2 
If yes – what do you smoke? Cigarettes 1 
 Tobacco/pipe 2 
 Snuff 3 
 Other 4 
If other, please describe 
If cigarettes, how many cigarettes do you smoke? Per day  
 Per week  
If tobacco, how many packages? Per day  
 Per week  
If snuff, how many parcels? per day  
 per week  
If other, describe frequency  
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How long have you been smoking (years)?  
Interviewer: Calculate pack years  
 
HYPERTENSION YES NO  
 
DIABETES MELLITUS YES NO 
 
OTHER: 
 
 
 
 
LIPID LOWERING MEDICATION: 
When stopped: 
 
ASPIRIN: 
When stopped 
 
OTHER PRESENT MEDICATION: 
 
 
 
 
VASCULAR HISTORY 
 
 
ANGINA OR MI YES 
 
Date: 
NO 
 
CABG OR 
ANGIOPLASTY 
YES 
 
Date: 
NO 
 
 
 
 
CVA or PVD YES 
 
Date: 
NO 
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Dietary Assessment 
 
Date done:……………………………………………………………………………. 
 
By whom:…………………………………………………………………………….. 
 
Examination 
 
Height: ……………………………………………… metres 
 
Weight: …………………………………………….. Kg 
 
BMI (ht/wt2):……………………………………………………………………….… 
 
Blood pressure:……………………………….….… mmHg 
 
Waist circumference:…………………………..….. cm 
 
Hip circumference:…………………………….….. cm 
 
Abdominal circumference:………………………... cm 
 
 
Arcus cornelias                                        Yes                                      No 
 
Xanthelasma                                            Yes                                      No 
 
Thickened Tendo-achilles                       Yes                                      No 
 
 
Carotid IMT: 
Left:………………………………………………………………………..…………….. 
 
Right: ……………………………………………………………………………………. 
 
Plaque: ………………………………………………………………………………...… 
 
Flow: ……………………………………………………………………………………. 
 
Pulses/bruits:………………………………………………………………………….… 
………………………………………………………………………………………….. 
Cor:…………………………………………………………………………………..…. 
……………………………………………………………………………………..…… 
Other:………………………………………………………………………………..….. 
………………………………………………………………………………………..… 
……..……………………………………………………………………………….…... 
………………………………………………………………………………….………. 
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ABSTRACT  
 
Background - Several studies have shown that increased carotid intima media thickness 
(CIMT) confers risk of future coronary artery disease (CAD) and stroke. The present 
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study aimed at investigating whether CIMT is a predictor of CAD in South African 
Black patients.  
 
Methods and Results - This was a prospective study of 53 patients, 41 men and 12 
women, with ages ranging from 30 to 70 years. All patients had undergone coronary 
angiography for suspected CAD. B-mode ultrasound measurement of the carotid 
intima-media thickness (CIMT) was carried in all patients, the operator being blinded as 
to the coronary angiography findings. Twenty-nine of the 38 (76 %) subjects with 
established CAD had increased CIMT, with an average mean CIMT of 1.13mm.  Single 
vessel disease was present in 12 people, double -vessel disease in 11 people and triple - 
vessel disease in 12 people. There was a significant positive linear trend between CIMT 
and the number of involved coronary vessels (p<0.0001, r=0.44). 
 
Conclusions – Increased CIMT correlated with evidence of angiographically proven 
CAD. The median percentile scores show a progressive increase as the number of 
vessel involvement increased. CIMT could be useful as a screening tool, for the 
presence of CAD, in the South African Black population.  
 
Lucas M Ntyintyane MB BCh1, Frederick J Raal FRCP, FRCPC, FCP (SA), MMed, 
PhD1, Geoffrey V Gill MA, MSc, MD FRCP2, Zaiboonnisa Holland MSc (Med)*  
 
1Carbohydrate and Lipid Metabolism Research Unit, Department of Medicine, 
University of the Witwatersrand, Johannesburg; 2 Liverpool School of Tropical 
Medicine, Liverpool, United Kingdom, * Department of Radiology, University of the 
Witwatersrand, Johannesburg .  
 
INTRODUCTION 
 
Urbanisation, industrialisation and socio-economic development have resulted in 
significant changes in lifestyles globally particularly in developing countries. (1) An 
epidemiological transition is now occurring in the developing world where the major 
causes of death are changing from infections to non-communicable diseases of lifestyle 
resulting in an increased prevalence of cardiovascular disease such as coronary heart 
disease. (2) The South African National Burden of Disease study for the year 2000 
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estimated that 17 % of all deaths were due to cardiovascular diseases. (3) Early 
detection of coronary artery disease (CAD) may well prove to be instrumental in 
introducing effective treatment and may contribute to reducing mortality. (4) 
Thickening of the intima-media is commonly recognised as the initial stage in the 
development of atherosclerosis. (5,6) Several studies have shown that increased carotid 
intima media thickness (CIMT) confers risk of future coronary heart disease and stroke. 
(7) The present study aimed at investigating whether CIMT is a predictor of CAD in 
South African Black patients.  
 
METHODOLOGY 
 
This was a prospective study of 53 patients, 41 men and 12 women, with ages ranging 
from 30 to 70 years. All patients had undergone coronary angiography for suspected 
CAD.  
 
Ultrasound Technique 
 
B-mode ultrasound measurement of the carotid intima-media thickness was carried out 
on all patients as a blind study, the operator being unaware of the coronary angiography 
findings. A standardised ultrasound technique was used, using a Toshiba System: 
Nemio Model SSA-550A. The transducer frequency was set at 11MHz for all patients. 
 
Measurements of the intima-media thickness was carried out at the optimum angle of 
interrogation (OAI), which allowed visualization of the flow tip divider, the common 
carotid artery (CCA), external carotid artery (ECA) and the internal carotid artery (ICA) 
from a single selected angle of the carotid arteries at the bifurcation. Doppler was used 
to verify the identification of the ECA and ICA. 
 
The carotid intima-medial thickness (CIMT) was measured when the two echogenic 
lines, representing the lumen-intima interface and the media-adventitia interface, were 
visualized over a length of ≥1cm. Measurements of the CIMT were done manually, 
using the calliper markers of the ultrasound unit.  
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The CIMT at the optimal angle of interrogation was measured as the area of maximum 
thickness at the near and far walls of the CCA, BIF and ICA bilaterally (a total of 12 
sites). In cases where calcified plaque obscured the IMT in the bulb, one wall was 
measured; the thickest measurement in each segment was imaged and recorded as the 
final measurement. The mean maximum IMT was recorded as the CIMT. Images were 
stored on a magnetic optical disc as well as on thermal paper. 
 
The CIMT was calculated as the average for 12 sites for all subjects, using the Excel 
programme for Windows XP. A mean value for the CIMT of > 0.8mm was classified as 
increased thickness. (8)  
 
Subjects with a previous myocardial infarction had to be at least 3 months post-
infarction before recruitment. As the study was designed to assess the effects of 
cardiovascular risk factors of lifestyle (hypertension, dyslipidaemia, smoking and 
obesity), subjects were excluded from the study if they were previously diagnosed with 
diabetes mellitus (DM) or genetic dyslipidaemia, or were positive for HIV infection. 
Subjects with overt renal, thyroid or liver disease were also excluded. Other exclusions 
were related to technical considerations which did not allow for measurement of the 
CIMT, including poor imaging with limited boundary visualization or when there were 
anatomical constraints, either a high carotid artery bifurcation or a short thick neck and 
where more than 2 segments were not visualized. 
 
Statistical Methods 
 
The Excel programme for Windows XP was used to calculate the mean maximum IMT 
(CIMT) of the carotid arteries. To assess the independent value of the CIMT as a 
predictor of CAD, linear and multiple regression analyses were done, using the GB –
STAT for Windows, Version 10, and Dynamic Microsystems Inc. 2004.  
 
To find how IMT behaves as a predictor of CAD severity in the presence of other 
important cardiovascular disease risk factors we included age, hypertension (> 140/90 
mm Hg or if the subject was on anti-hypertension medication), abnormal glucose 
tolerance, central obesity as assessed by abdominal circumference, dyslipidaemia and 
cigarette smoking.   
 
 
10
 
RESULTS 
 
Among the 53 participants, coronary angiography results showed that 15 people had no 
evidence of CAD. This constitutes the Control group. Of the 15 subjects in the control 
group, ten were males and five females, a ratio of 3 to 1. The mean age was 47 years, 
with an age-range of 30-65 years. Although there was no evidence of CAD on 
angiography, eight of the 15 (53%) had increased CIMT. The mean CIMT was 
calculated as 0.998 mm. Four subjects had hypertension as the only risk factor for 
CAD, and the CIMT values of this group had a median CIMT percentile value (1.22 
mm), which was as great as that of subjects with multiple risk factors.    
 
Characteristics of the study subjects (patients with evidence of coronary artery disease 
on coronary angiography). 
 
 The Study group consisted of the 38 subjects with evidence of CAD on coronary 
angiography, defined as lesions greater than 50% in one or more of the major coronary 
vessels (TABLE 1).   Single vessel disease was present in 12 people, double -vessel 
disease in 11 people and triple - vessel disease in 12 people.  Coronary angiography 
results were not available for 3 study subjects.  In the study population 29 of the 38 
subjects (76 %) had increased CIMT - with a mean CIMT of 1.13mm. The mean age for 
the Study group was 55.4 years, with ages ranging from 36 to 69 years.  Linear 
regression analysis for CIMT against age shows that increasing age is related to 
increase CIMT (r = .223, p = 0.17).  Hypertension, defined as a blood pressure of > 
140/90 mmHg or if the subject was on antihypertensive medication, was very prevalent, 
95 % of the study subjects being hypertensive. Obesity, particularly abdominal obesity 
(defined as an abdominal circumference of > 92 cm in males and > 88 cm in females) 
was also highly prevalent, 79 % of the study subjects having increased abdominal 
circumference. Smoking was also more prevalent in the study group, 62.5 % of the 
subjects being current or ex-smokers. 
  
Although subjects with diabetes were excluded from the study, 55 % were found to 
have abnormal glucose tolerance. All the patients with a raised fasting glucose had 
increased CIMT (100%). There was a good correlation of CIMT with fasting blood 
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glucose levels of the whole group using simple linear regression analysis (r = 0.35; 
P=0.03). In addition, 100% of subjects with high fasting blood glucose had an increased 
CIMT. 
 
Of the patients who were found to have impaired glucose metabolism on glucose 
tolerance tests, 76.2% had increased CIMT.  However, those with normal glucose 
metabolism (neither raised fasting blood glucose nor an abnormal glucose tolerance 
test) had a similar percentage of subjects with increased CIMT, 76.4%. 19 patients (5 
%) had raised fasting triglyceride (TG) levels of  > 1.7 mmol/l, of which 78.95% had 
increased CIMT. However the percentage with increased CIMT was similar in the 19 
subjects with normal triglyceride levels (73.68%). Subjects with high LDL-C levels 
(LDL-C > 3 mmol/l) had increased CIMT in 93.75 % of cases. LDL-C levels also 
showed a strong positive correlation with CIMT.    
 
Correlation with extent of coronary vessel involvement 
 
The median percentile scores showed a progressive increase as the number of vessel 
involvement increases. The median CIMT average was 0.88 mm on those with a single 
vessel disease, 1.08 mm on those with double vessel diseases and 1.19 mm on those 
with triple vessel disease (FIGURE 1).  There was a significant positive linear trend 
between CIMT and the number of involved vessels (r = 0.44, p< 0.0001).  
 
DISCUSSION 
 
The study findings support the hypothesis that CIMT is a predictor of the presence and 
extent of CAD in South African black patients. (9) Predictors of CIMT included several 
of the classical CAD risk factors namely age, hypertension, dyslipidaemia, abdominal 
obesity, and smoking and glucose intolerance.  The impact of these risk factors on 
CIMT has been previously well described. (10, 11)  On univariate analysis the key risk 
factors associated with increased CIMT were hypertension and raised fasting glucose. 
(12)  
   
Bearing in mind that diabetics were excluded from the study, the effect of high fasting 
blood glucose levels on the CIMT was significant. Thus in this study, high fasting 
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glucose levels, which is also an important component of the metabolic syndrome, was 
an important factor associated with increased CIMT. 
 
 The median percentile scores of CIMT show a progressive increase as the number of 
coronary vessel involvement increased.  The findings in the study support previous 
studies (13, 14), where increased CIMT was correlated with evidence of 
angiographically proven CAD.  The study by Kablak-Ziembicka et al showed that 
increased CIMT was positively and linearly related to CIMT, subjects with a greater 
number of vessel involvement showed greater increases in CIMT. In addition their 
study showed that a CIMT over 1.15mm was predictive of a 94% likelihood of having 
CAD. The study by Geroulakos et al (15) also showed a significant positive linear trend 
between CIMT and the number of involved vessels. The study also demonstrated a high 
positive predictive value and specificity for the presence of CAD if a CIMT >0.85 mm 
correlated for age, is used as a cut-off point for the prediction of CAD. (16) 
 
Table 1:  Clinical characteristics of the studied patients with CAD and without 
CAD on coronary angiography.  
 
Table 1     Clinical  Characteristics of the Studied Patients 
 No CAD 
(n = 15) 
% 
CAD 
(n =38) 
% 
Hypertension  (Blood pressure > 140/90 mmHg or on 
antihypertensive therapy) 
60 97 
Increased Abdominal Circumference ( male > 92 cm , 
females > 88 cm )  
33.3 79.1 
Abnormal Glucose Tolerance  0 55.26 
Raised Triglycerides  ( > 1.7 mmol/l)  26.7 50 
Low HDL Cholesterol  (men <1.0 mmol/l, women < 
1.3mmol/l) 
33.33 42.10 
Raised LDL Cholesterol (> 3 mmol/l)  13.33 42.10 
Cigarette Smoking / Previous Smokers 20 62.5 
Mean CIMT(mm) 0.998 1.13 
% with increased CIMT (> 0.8 mm)  53 76 
 
 
 
The limitations are inherent in the study design, which recruited subjects undergoing 
coronary angiography for a suspected clinical diagnosis of CAD. The study population, 
a total of 53 subjects, was thus highly selected, without the possibility of case matching, 
particularly for the dominant risk factor, hypertension, which was present in every study 
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subject but one. (17) Future researchers will be faced with the challenge of recruiting a 
larger group of participants to allow for a controlled study within this population with a 
rising prevalence of CAD.  Better definition of the impact of each of the risk factors on 
CIMT and consequently CAD should be the role of future studies. 
 
FIGURE 1.   CIMT WITH EXTENT OF VESSEL INVOLVEMENT 
 
 
CIMT
NO CAD 1 VES 2 VES 3 VES
0.0
0.5
1.0
1.5
2.0
2.5
25%-75% Median 10%-90% 
CORRELATION WITH EXTENT OF VESSEL INVOLVEMENT
PERCENTILE CIMT VALUES IN CAD
 
 
The above graph indicates a correlation of the CIMT and the extent of CAD 
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Abstract 
 
Background: Metabolic syndrome (MetS) and coronary artery disease (CAD) are 
increasing in urban black South Africans during their transition from a rural to a 
western lifestyle. Inflammation is frequently associated with MetS and CAD. This 
study evaluated markers of inflammation in black CAD patients, some of whom had 
MetS. 
 
Methods: MetS was defined according to International Diabetes Federation criteria. 
Inflammatory markers leptin, adiponectin and high sensitivity C-reactive protein (hs-
CRP) were measured in 40 patients and 20 control subjects. 
 
Results: MetS was present in 23 patients and absent in 17 patients. Leptin was the only 
significantly higher marker in patients with MetS compared to patients without MetS (p 
< 0.01). Leptin was higher in women than men (p < 0.01), and higher in both genders 
with MetS (p < 0.03 and p < 0.04, respectively). Leptin levels rose significantly with 
increasing MetS criteria (p < 0.05). hs-CRP concentrations were elevated in both patient 
groups. Positive correlations were found between leptin and body mass index (BMI) (r 
= 0.7107; p < 0.0001), waist circumference (WC) (r = 0.4981; p < 0.002), and hs-CRP 
(r = 0.3886; p <0.02). 
 
Conclusions: Leptin differentiated between CAD patients with and without MetS, and 
determined MetS status in women and men. Leptin was the only marker that increased 
with additional MetS criteria. Elevated hs-CRP concentrations indicated an 
inflammatory state in CAD patients. Association of leptin with BMI, WC and hs-CRP 
revealed a close link with MetS, obesity and inflammation in urban black South African 
CAD patients. 
 
Introduction 
 
The metabolic syndrome (MetS) is widely used nowadays to describe a cluster of 
metabolic abnormalities that predisposes an individual to cardiovascular disease and 
diabetes mellitus (DM).1 During the past two decades, there has been a striking increase 
in the prevalence of MetS in parallel with the global epidemic of obesity. Numerous 
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researchers have found varying prevalence rates in populations from diverse ethnic 
backgrounds ranging from the Japanese (11%),2 Arabs (16%),3 Asian Indians (35%)4  to 
black (34%) and white (39%) Americans.5 An even higher rate (58%) was reported by 
us in South African Blacks with coronary artery disease (CAD).6  
 
Thirty years ago, CAD was a rarity in the black population of South Africa.7 In recent 
times, however, accumulating evidence shows that CAD is emerging rapidly in this 
group as they migrate from rural to urban areas and adopt a western lifestyle of less 
physical activity and a diet high in refined foods.8,9 New data from the Heart of Soweto 
study of a large urbanized black community and our own research has found a high 
prevalence of risk factors, namely, obesity, hypertension, dyslipidemia and 
hyperglycemia.10,11,12 These multiple risk factors that relate to CAD are also 
documented criteria for MetS.1 Other population-based studies by Lakka et al. 13 and 
Isomaa et al.14 of the relationship between CAD and MetS have demonstrated that 
patients with the syndrome had a two- to four-fold increased risk of mortality. 
Therefore, identifying MetS is clinically important mainly because of its association 
with CAD. 
 
There is growing support for the concept that inflammation is involved in the initiation 
and progression of CAD15, 16, 17 and a proinflammatory state is considered to be a 
characteristic feature of MetS.18 It is acknowledged that obesity, particularly abdominal 
obesity, which is the primary diagnostic criterion for MetS, is also accompanied by 
systemic low-grade inflammation.19 However, the link between CAD, MetS, obesity 
and inflammation is not yet fully understood. One postulated mechanism is that 
adipocytes secrete increased levels of cytokines into the circulation which may induce 
an inflammatory response throughout the body.20 “Adipokines”—cytokines of the 
adipose tissue, including leptin and adiponectin, in turn, stimulate the production by the 
liver of large amounts of acute phase reactants such as C-reactive protein (CRP).20 This 
inflammatory process in atherosclerotic arteries may lead to elevated blood levels of 
these inflammatory markers in patients with CAD.17 Therefore, the value of measuring 
them in CAD patients lies in the ability of these markers to detect inflammation and 
potentially identify the presence of MetS. 
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Leptin, from the Greek leptos for thin, is probably the best characterized of the 
inflammatory markers. It is involved in the regulation of appetite and energy 
homeostasis, and leptin levels are elevated with increased adiposity21. Adiponectin is 
distinct from the other adipokines in that it is inversely related to obesity.22 CRP, which 
was originally discovered as a protein that reacted with the C-polysaccharide of 
Pneumococcus, rises dramatically during the acute phase of the inflammatory cascade23.  
A high sensitivity CRP (hs-CRP) assay designed for greater accuracy in measuring the 
lower concentrations of CRP at the early onset of inflammation is used currently for 
cardiovascular risk assessment.  At this stage of black South Africans’ epidemiologic 
transition, relatively little is known about leptin, adiponectin and hs-CRP in this 
population. The aim of this study was to evaluate these markers in urban black patients 
with CAD, some of whom also had MetS.  
 
Methods 
 
Patients and control subjects 
 
Forty patients (33 men, 7 women) and 20 control subjects (13 men, 7 women) who 
attended the Chris Hani Baragwanath Hospital in Soweto, one of the largest hospitals in 
the southern hemisphere, participated in the study. Patients and control subjects were 
classified according to the number and extent of lesions in coronary arteries, which 
were verified by a coronary angiogram performed in the preceding 24 months. All of 
the patients had significant CAD, which was defined as greater than 50% lesions in one 
or more major coronary arteries. None of the control subjects had evidence of coronary 
atherosclerosis on coronary angiography. Patients who had a previous myocardial 
infarction (MI) were at least three months post-MI before the study started. The 
majority of patients (95%) and control subjects (75%) had moderate hypertension 
(blood pressure ≥ 130/85 mmHg) and were taking antihypertensive medication. 
 
Patients who had a dominant risk factor such as severe hypercholesterolemia or DM, 
which had been previously diagnosed by a physician, and were using medication, were 
excluded. Other exclusion criteria were: human immunodeficiency virus (HIV)-positive 
status; overt liver, renal or thyroid disease; and smoking more than 20 cigarettes per 
day. All participants gave written informed consent to take part in the study, which was 
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approved by the Human Research Ethics Committee of the University of the 
Witwatersrand, Johannesburg, South Africa. 
 
Definition of the metabolic syndrome 
 
MetS was defined according to International Diabetes Federation (IDF) criteria1, which 
require waist circumference (WC) ≥ 94 cm in men or ≥ 80 cm in women plus any two 
or more of the following four risk factors: (1) triglycerides (TG) ≥ 1.7 mmol/L; (2) 
high-density lipoprotein cholesterol (HDL-C) < 1.03 mmol/L in men or < 1.29 mmol/L 
in women; (3) systolic blood pressure (BP) ≥ 130 mmHg, diastolic BP ≥ 85 mmHg, or 
on treatment ; and (4) fasting plasma glucose ≥ 5.6 mmol/L or previously diagnosed 
DM. Because the definition does not specify WC measurements for black Africans, 
European WC measurements were applied in this study.  
 
Design 
 
Four weeks before the study started, lipid-lowering medications such as statins and 
fibrates were discontinued. The night before the test, participants were asked to refrain 
from smoking and fast for 12 hours. On the day of the study, each participant 
underwent a clinical examination that included an interview and a venipuncture. Height, 
weight, WC and hip size were measured, and body mass index (BMI) and waist-to-hip 
ratio (WHR) were calculated. Fasting blood samples were analyzed for triglycerides 
(TG), high density lipoprotein cholesterol (HDL-C), glucose, leptin, adiponectin and hs-
CRP. Questionnaires were used to obtain information on demographic variables, 
medical history, medication use, dietary habits, physical activity and smoking status. 
 
Laboratory assays 
 
Concentrations of TG, HDL-C, and glucose were determined by enzymatic colorimetric 
methods using a Hitachi automated analyzer and reagents were supplied by Roche 
Diagnostics GmbH (Mannheim, Germany) (reference ranges: TG 0.5—1.5mmol/L; 
HDL-C > 1.2 mmol/L; glucose 3.9—5.5 mmol/L). Leptin and adiponectin levels were 
measured by enzyme-linked immunosorbent assays (ELISA) (R&D Systems Inc., 
Minneapolis, MN) (reference ranges: leptin 0.5—12.7 ng/ml in men and 3.9—30.0 
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ng/ml in women; adiponectin 4.0—20.0 µg/L in men and 5.0—28.0 µg/L in women). 
An immunoturbidimetric assay was used to measure hs-CRP (Tina-quant®, Roche 
Diagnostics GmbH, Mannheim, Germany) (reference intervals: low risk < 1.0 mg/L, 
average risk 1.0—3.0 mg/L, high risk > 3.0 mg/L). 
 
Statistical Analysis 
 
Data were analyzed using the GB-STAT program (Dynamic Microsystems, Inc., Silver 
Spring, MD) with a p value < 0.05 considered significant. Analysis of variance 
(ANOVA) was used to compare more than two groups. Continuous variables were 
compared by the t-test, Mann-Whitney U-test, or Wilcoxon Signed-Rank test for 
parametric or non-parametric data, respectively. Results are expressed as mean ± 
standard deviation (SD) or as proportion (%). Linear regression analysis was performed 
to reveal any significant correlations. 
 
Results 
 
Classification of the metabolic syndrome 
 
Measurements of WC and the number of other criteria for MetS were assessed 
according to the IDF definition. This allowed classification of the 40 patients into two 
groups. MetS was present in 23 patients and absent in 17 patients. Three of the control 
subjects had MetS as defined, but they had no evidence of CAD on angiography and, 
therefore, were included in the study. 
 
Fasting profiles of the study groups 
 
Table 1 summarizes the mean anthropometric measurements and fasting biochemical 
variables of all the CAD patients, CAD patients with and without MetS, and control 
subjects. Patients and control subjects were matched for age, WHR, BMI and WC, all p 
> 0.5. BMI was significantly higher in patients with MetS compared to those without 
MetS (p < 0.0001) and lower in patients without MetS than control subjects (p < 0.02). 
As expected, WC, which is the main diagnostic criterion for MetS, was significantly 
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higher in patients with MetS than patients without MetS (p < 0.0001) and control 
subjects (p < 0.01).  
 
Systolic and diastolic BP readings were highest in patients with MetS. Most of the 
patients with MetS (96%) and without MetS (94%) had moderate hypertension and 
were taking antihypertensive medication. Patients with MetS had a slightly elevated TG 
level and a slightly lower HDL-C concentration than patients without MetS and control 
subjects. Glucose concentrations in both MetS patient groups were higher than control 
subjects, significantly so in patients with MetS (p < 0.01). 
 
Leptin levels were significantly higher in patients with MetS than patients without MetS 
(p < 0.01) and also higher in control subjects than patients without MetS (p < 0.02). 
Adiponectin level in patients with MetS was slightly lower than in the other groups. 
Concentration of hs-CRP was slightly but not significantly higher in patients with 
MetS, and both groups of patients were higher than control subjects, significantly so in 
patients with MetS (p < 0.01). 
 
Marker measurements grouped by gender and MetS status 
 
Table 2 presents the mean marker measurements grouped by gender in patients with 
and without MetS. Leptin was significantly higher in women than men (p < 0.01). 
Leptin levels in women and men with MetS were significantly higher than women and 
men without MetS (p < 0.03 and p < 0.04, respectively). There were no substantial 
differences between women and men in either adiponectin or hs-CRP concentrations. 
 
Marker measurements grouped by number of MetS criteria 
 
Table 3 shows the mean marker measurements grouped by the number of criteria for 
MetS. When the markers were analyzed according to increasing MetS criteria, only 
leptin showed a statistically significant difference in levels as the number of MetS 
criteria increased (p < 0.05). Leptin levels increased progressively, with those patients 
who had the most criteria having the highest level. In general, concentrations of 
adiponectin decreased and hs-CRP increased with additional criteria, but values did not 
change in a linear manner and the differences were not significant.  
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Linear regression analysis 
 
Linear regression analysis of the total patient group (n = 40) in which leptin, 
adiponectin, and hs-CRP were the dependent variables and age, WHR, BMI, WC, 
systolic and diastolic BP, TG, HDL-C, and glucose were the independent variables, 
revealed that the highest positive correlations were between leptin and BMI (r = 0.7107; 
p < 0.0001), leptin and WC (r = 0.4981; p < 0.002), and leptin and hs-CRP (r = 0.3886; 
p < 0.02) (Fig. 1). Leptin also correlated with adiponectin albeit in the opposite 
direction (r = − 0.3411; p < 0.04), whereas hs-CRP correlated positively with BMI (r = 
0.3400; p < 0.04). 
 
Discussion 
 
This study assessed the integrated relationship between MetS, obesity and inflammation 
in urban South African black patients with CAD, some of whom also had MetS. The 
main findings were that, of the three markers, only leptin was significantly higher in 
patients with MetS compared to patients without MetS. Leptin levels in both women 
and men with MetS were significantly higher than in those without MetS. When the 
markers were analyzed according to increasing MetS criteria, leptin alone rose 
significantly with more criteria. We also found that concentrations of hs-CRP were 
elevated both in CAD patients with and without MetS. In the total patient group, leptin 
correlated significantly with indicators of obesity (BMI, WC) and inflammation (hs-
CRP). 
 
The higher leptin levels measured in our patients with MetS reflected their greater 
degree of body fat mass and abdominal obesity compared to those without MetS. 
Recognized gender-specific differences documented in the literature24 were also noted 
as leptin levels in our patients were higher in women than men. The significant increase 
in leptin levels when additional MetS criteria were present was an interesting finding 
that has not been observed before in black South African patients. However, the 
inclusion in our study of patients with established CAD implies that most of them 
would have had more than one of the five risk factors that are common to both CAD 
and MetS. Indeed, our earlier research has shown that increased WC, together with 
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hypertension and elevated glucose concentration comprised the most frequent 
combination (20.8%) in our MetS patients.25 The inverse relationship between obesity 
and adiponectin is well known22 and because our patients with MetS had greater WC 
and BMI, it follows that they would have had a lower adiponectin level than patients 
without MetS. 
 
A linear increase in hs-CRP concentrations with increasing components of MetS has 
been reported by Laaksonen et al.26 and Lee et al.27 Although hs-CRP concentrations in 
our patients generally increased with additional criteria, values did not change in a 
straight line and the differences were not significant. In contrast to a study by Florez et 
al.28 that showed differences between hs-CRP concentrations and MetS status, we 
found that hs-CRP concentrations were not significantly different in our patients with 
and without MetS. In both groups, however, hs-CRP concentrations were elevated to 
twice the high risk level of 3.0 mg/L, which was indicative of inflammation. A feasible 
explanation for this finding might be that because patients in both groups had 
established CAD, they exhibited this underlying feature of the disease. It should be 
noted that hs-CRP is a non-specific indicator of inflammation29 and it is possible, 
therefore, that the relatively higher hs-CRP concentrations were caused by other 
unknown inflammatory conditions. 
 
Previous studies, including our own contribution to a report on body composition, have 
stated that BMI and WC are important determinants of increased leptin levels.30, 31, 32 
Linear regression analysis of our total group of patients confirmed that the highest 
correlation was between leptin and BMI. Of the five MetS criteria, WC correlated 
strongly with leptin, a result that is consistent with other studies linking obesity with 
increased leptin levels and an unfavourable metabolic profile.33, 34 Positive correlations 
between leptin and hs-CRP, as well as hs-CRP and BMI suggested that these markers 
were closely related to obesity and inflammation in our CAD patients. 
 
Our study was limited by the relatively small groups of patients and control subjects, 
and the low number of patients who fulfilled all five criteria for MetS. Although there 
appeared to be differences of reasonable size in adiponectin and hs-CRP concentrations 
from one to five criteria, values did not change in a linear manner and this is the likely 
reason for the lack of statistical significance. It was not our intention to recruit more 
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men than women, but because CAD is more prevalent in men, the majority of 
participants in our study happened to be men. 
 
We concluded that leptin, as well as being an indicator of obesity, was also a useful 
marker of inflammation in our CAD patients. Of the three markers we analyzed, leptin 
alone was able to differentiate between CAD patients with and without MetS, and to 
determine MetS status in women and men. Leptin was the only marker that had a 
significant relationship with increasing criteria for MetS. Thus, in addition to existing 
MetS criteria, leptin measurements might be helpful in assessing MetS status. Our 
results confirmed that elevated hs-CRP concentrations indicated an inflammatory state 
in CAD patients, irrespective of the presence or absence of MetS. Finally, the 
association of leptin with BMI, WC and hs-CRP revealed a close link between MetS, 
obesity and inflammation in urban South African black patients with CAD. 
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Table 1: Anthropometric measurements and fasting biochemical variables of 
black coronary artery disease patients with and without the metabolic 
syndrome, and control subjects 
 
 All CAD 
patients 
 
 
 
(n = 40) 
CAD patients 
with MetS 
 
(n = 23) 
CAD patients 
without MetS 
(n = 17) 
Control 
subjects 
 
 
(n = 20) 
 
Age (years) 54.1 ± 8.8 54.4 ± 9.0  53.7 ± 8.6 49.8 ± 9.8 
 
WHR 0.92 ± 0.06 0.93 ± 0.05 0.91 ± 0.08 0.91 ± 0.07 
 
BMI (kg/m2) 28.2 ± 4.9 30.7 ± 4.8 
b 24.9 ± 2.7 d 29.1 ± 6.8 
 
WC (cm) 96.8 ± 10.5 104 ± 7.2 
b, c  87.7 ± 6.7 93.5 ± 14.3 
 
Systolic BP (mmHg) 124 ± 15 128 ± 15 119 ± 12 124 ± 14 
 
Diastolic BP (mmHg) 77 ± 9 78 ± 10 76 ± 6 75 ± 8 
 
Triglycerides (mmol/L) 1.7 ± 1.0 1.8 ± 0.9 1.6 ± 1.0 1.3 ± 0.4 
 
HDL-C (mmol/L) 1.2 ± 0.3 1.1 ± 0.3 1.2 ± 0.3 1.3 ± 0.5 
 
Glucose (mmol/L) 5.2 ± 0.8  5.4 ± 0.8 
c 5.0 ± 0.9 4.6 ± 0.8 
 
Leptin (ng/ml) 11.1 ± 9.6 14.7± 10.8 
a 6.0 ± 4.0 d 18.9 ± 20.0 
 
Adiponectin (ug/ml) 19.5 ± 17.2 17.7 ± 17.2 21.4 ± 17.3 19.0 ± 21.5 
 
hs-CRP (mg/L) 6.8 ± 7.4  7.2 ± 7.5 
c 6.2 ± 7.5 3.6 ± 3.7 
 
Data are expressed as mean ± SD or %. 
 
a p < 0.01 CAD patients with MetS vs. CAD patients without MetS 
b p < 0.0001     “         “          “        “    vs.       “          “         “           “ 
c p < 0.01 CAD patients with MetS vs. control subjects 
d p < 0.02 CAD       “      without MetS vs.  “           “ 
 
 
 
30
CAD: coronary artery disease; MetS: metabolic syndrome; WHR: waist-to-hip ratio; BMI: body 
mass index; WC: waist circumference; HDL-C: high density lipoprotein cholesterol; BP: blood 
pressure: hs-CRP: high sensitivity C-reactive protein. 
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Table 2: Marker measurements in black coronary artery disease patients grouped by gender and metabolic syndrome status 
 
 
 Gender Women Men 
 Women            (n = 
7) 
Men                 (n = 
33) 
with MetS         (n = 
6) 
without MetS    (n = 
1) 
with MetS         (n = 
17) 
without MetS      (n = 
16) 
Leptin (ng/ml)         
 
21.5 ± 12.9a 8.9 ± 7.2 23.8 ± 12.4b 7.6 ± 0.0 11.5 ± 8.4c 5.8 ± 4.1 
Adiponectin (µg/ml) 
 
13.0 ± 8.9 20.9 ± 18.3 19.1 ± 8.9 21.2 ± 0.0 19.8 ± 11.6 21.4 ± 17.9 
hs –CRP (mg/L) 
 
8.5 ± 13.7 6.4 ± 6.0 3.6 ± 2.6 1.0 ± 0.0 6.4 ± 4.0 6.4 ± 7.6 
 
Data are expressed as mean ± SD. 
 
a p < 0.01 Women vs. men 
b p < 0.03 Women with MetS vs. women without MetS 
c p < 0.04 Men with MetS vs. men without MetS 
 
hs-CRP: high sensitivity C-reactive protein; MetS: metabolic syndrome 
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Table 3: Marker concentrations at increasing numbers of criteria for the 
metabolic syndrome in black coronary artery disease patients 
 
 
Number of MetS criteria Leptin (ng/ml) Adiponectin (µg/ml) hs-CRP (mg/L) 
1 
 
3.3 ± 1.6 a 26.8 ± 17.1 6.6 ± 5.3 
2 
 
8.9 ± 4.7 17.2 ± 11.9 6.7 ± 8.9 
3 
 
10.9 ± 8.3 17.9 ± 19.3 7.0 ± 10.5 
4 
 
13.4 ± 10.0 23.2 ± 21.8 7.6 ± 5.1 
5 
 
21.9 ± 13.7 9.6 ± 2.1 6.3 ± 0.0 
 
Data are expressed as mean ± SD. 
 
a p < 0.05 Difference in concentrations from 1 to 5 criteria for MetS 
 
hs-CRP: high sensitivity C-reactive protein; MetS: metabolic syndrome 
 
 
Legend 
 
Fig. 1 Linear regression plots of patients with CAD (n = 40) displaying significant 
positive correlations between (a) leptin and body mass index (r = 0.7107; p < 0.0001); 
(b) leptin and waist circumference (r = 0.4981; p < 0.002); (c) leptin and high sensitivity 
C-reactive protein (r = 0.3886; p < 0.02). 
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Dietary intake, socio demographics and physical activity of a black urbanised South 
African population with coronary artery disease compared to healthy volunteers 
 
ABSTRACT 
 
OBJECTIVE: To investigate the role of diet, socio-demographics and physical activity 
in a black South African population with coronary artery disease compared to a healthy 
control group. 
 
DESIGN: Case control study 
 
SETTING:  Chris Hani Baragwanath Hospital, Soweto, South Africa 
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SUBJECTS: Forty black patients with documented CAD and twenty control volunteers 
who were matched for age, body mass index, waist circumference and waist-hip ratio 
were included.   
 
OUTCOME MEASUREMENTS: Anthropometrical and biochemical variables as well 
as socio-demographics, physical activity and quantitative food intake were determined. 
 
RESULTS: No differences were found between the dietary intake, physical activity or 
socio demographics of the two groups, except for vitamin C intake (p=0.049), with the 
controls having a median vitamin C intake within the DRI range (94mg) and the CAD 
patients an intake well below (47mg).  Compared to dietary guidelines for prevention of 
CAD, saturated fatty acid and cholesterol intake were above and fibre, folate and vitamin 
E all below the recommended intake for both groups.  In order to determine the role of 
urbanisation on the diet, the study population’s diet was compared to that of a traditional 
rural group and an urban group with comparable socio-demographic status.  The study 
population’s diet was found to be more westernised compared to both the rural and urban 
group. 
 
CONCLUSION: When confounding factors, age and obesity were accounted for, there 
were no differences in the diet, physical activity or socio-demographics of the CAD 
patients and control group, except for vitamin C intake with both groups having a 
micronutrient intake below the recommended level.  While diet is known to be affected 
by urbanisation, differences in dietary intakes were observed between the two urban 
groups, regardless of the similarity in their socio-demographic profile.  
 
INTRODUCTION 
 
The prevalence of cardiovascular disease (CVD) and its risk factors in developed 
countries has been well documented.1  However, data is emerging regarding the 
disconcerting increase in prevalence of CVD in developing countries.  A systematic 
analysis of population health data found that when dividing countries into 2 categories, 
  
 
36
that is low and middle income together and then high income countries, Ischemic heart 
disease (IHD) and cerebrovascular disease (stroke) were the leading cause of death in 
both of these groups.  Together they were responsible for more than one fifth of all deaths 
worldwide.2 The large majority of deaths due to IHD (5.7 million of the 7.1 million total 
deaths) were in the lower and middle-income countries.2 CVD, particularly coronary 
artery disease (CAD) was always considered to be rare in the black South African 
population, but studies are showing an increase in prevalence with urbanisation.3,4 In the 
early 1990’s approximately 70 black patients with CAD were admitted annually at the 
Chris Hani Baragwanath Hospital in Soweto (Johannesburg), this has now increased to 
around 165 cases in 2006.5  Although there is a definite increase, the increase in the 
volume of cases has been less than would be expected, compared to the very high 
prevalence of cardiovascular risk factors in this population.4,5 
 
Risk factors such as smoking, elevated low-density lipoproteins (LDL), low high- density 
lipoproteins (HDL), high blood pressure, elevated glucose, physical inactivity, obesity as 
well as diet have been proven to be causal risk factors for the development of CVD.6  
Epidemiological, experimental and clinical trial evidence have demonstrated a 
relationship between diet and many of the other risk factors such as abnormal blood lipid 
levels, blood pressure, glucose level and obesity.7,8  For example, diets high in saturated 
fatty acids, cholesterol and animal fat have been shown to increase LDL cholesterol 
levels.8  The westernised diet pattern (higher intake of red meat, processed meat, refined 
grains, sweets, french fries and high fat dairy products) has been shown to predict 
incidence of CHD.9  When looking at the dietary intake in the South African population, 
there have been shifts in diet intake to a less prudent diet over the past 2 decades.10  
These shifts are occurring at an increased momentum, particularly in the black South 
African population, where with urbanisation, there has been a definite increase in fat 
consumption and a decrease in carbohydrate consumption, as has been observed in the 
North West province of South Africa (THUSA study), as well as in other developing 
countries.11,12.  Shifts towards a more westernised diet have however also been observed 
in rural communities.10,13 With urbanisation, there is also an increase in socio-economic 
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status, which is usually accompanied by an increase in other risk factors for CAD, such 
as obesity and physical activity (PA).12 
 
Physical activity has been suggested to be a contributing factor to a decreased risk of 
CVD, due in part to favourable effects on blood pressure, triglyceride (TG) levels, HDL 
cholesterol levels, insulin sensitivity and body weight.14 In South Africa only a few 
studies have been done to quantify PA patterns in healthy volunteers and to relate PA to 
CVD risk factors.  In the Western Cape, lack of PA was found to be a significant risk 
factor for non-insulin diabetes mellitus,15 while in the North West province (THUSA 
study), physical inactivity was associated with a number of CVD risk factors, especially 
in overweight black women.  Thus indicating the potential role of PA in decreasing CVD 
risk.16 
 
While ample evidence exists regarding the role of dietary intake, PA and socio-
demographics in CVD in westernised populations, no data is available on black South 
Africans with diagnosed CAD.  This study therefore investigates the role of diet, socio-
demographics and PA in CAD in the black South African population. 
 
METHODS 
 
CAD and control patients 
 
Forty black patients (33 men, 7 women) with documented CAD were included in this 
study.  Coronary artery disease was defined as more than 50% lesions in one or more 
major coronary arteries, seen with a diagnostic coronary angiogram in the previous 24 
months.  Subjects with previous myocardial infarction (MI) had to be at least 3 months 
post-MI before the study.  Patients with severe hypercholesterolemia (untreated total 
cholesterol (TC) of greater than 7.5mmol/L or clinical features of familial 
hypercholesterolaemia), previously diagnosed diabetes mellitus and who were HIV-
positive were excluded.  Other exclusion criteria included any overt liver, renal or thyroid 
disease and smoking in excess of 20 cigarettes per day.  Four weeks before the study 
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started, lipid-lowering medications such as statins and fibrates were discontinued.  Any 
other drugs that might alter lipid levels and/or insulin resistance such as thiazide 
diuretics, beta-blockers or steroids were stopped three days before tests began.  Patients 
and controls were also asked to refrain from smoking and to fast for 12 hours before the 
tests. 
 
Twenty volunteers (13 men and 7 women) who were matched with the cases for age, 
body mass index (BMI), waist circumference (WC) and waist-hip ratio (WHR) were 
included as a control group.  This was done in order to exclude the confounding effects of 
age and weight differences.   The control group had no evidence of coronary 
atherosclerosis on coronary angiography.  The same exclusion criteria, as for the CAD 
patients, applied for the control group. 
 
STUDY DESIGN 
 
All participants underwent a structured physical examination, and a questionnaire was 
used to obtain information such as demographic information, medical history, medication 
use and smoking status.  A fasting venipuncture and anthropometrical measurements, 
which consisted of height, weight and waist and hip circumference was done.  Height and 
weight were measured to the nearest 0.5cm and 0.1kg, respectively, and used to calculate 
the body mass index (BMI).  The waist circumference was measured using a non-elastic 
measuring tape, at the midpoint between the lowest rib and the iliac crest, to the nearest 
0.1cm.   
 
Serum was collected for testing of C-Reactive protein, TC, HDL cholesterol and TG, 
while plasma for glucose determination was collected in fluoride tubes.  Measurements 
were determined by enzymatic colorimetric methods using a Hitachi automated clinical 
analyser and reagents were supplied by Roche Diagnostics (GmbH, Mannheim, 
Germany).  Calculation of LDL cholesterol concentrations was based on the Friedewald 
equation17.  LDL subfractions were measured in serum by linear, polyacrylamide gel 
electrophoresis using a Quantimetrix Lipoprint System LDL Subfractions kit 
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(Quantimetrix, CA, USA).  The method resolves the LDL subfractions into profiles 
consisting primarily of large, buoyant particles or predominantly small, dense particles. 
 
A standardised quantitative food frequency questionnaire (FFQ) was used to determine 
the dietary intake of the cases and controls.18 A registered dietician administered the 
questionnaire; with the aid of “The nutrition transition among the African population of 
North West” food portion photo book to estimate portion sizes.19  The nutrient intakes 
were analysed using the Medical Research Council’s FoodFinder3 program, which is 
based on the South African Food composition tables.20  A standardised Physical Activity 
questionnaire21 was also administered by a registered dietician.  Physical activity is 
reported as Physical Activity Index (PAI).  The PAI divides activity into 1 of 3 
categories, namely inactive (1- 3.33), moderately active (3.34 – 6.67) and most active 
(>6.67).22 
 
STATISTICAL ANALYSIS 
 
Statistical analysis of data was done using the computer software package Statistica® 
version 8.23  Data is reported as median [25 – 75 percentile] for non-parametric data or as 
mean (Standard deviation) for parametric data.  A p-value of less than or equal to 0.05 
was regarded as statistically significant.  Independent T-tests were done on parametric 
data and for non-parametric data, the Mann Whitney U test was used when comparing the 
CAD patients to the control group.  For the categorical variables, the Chi-square test was 
used.  Spearmann Rank order correlations were also done to determine associations 
between risk factors and diet, PA and socio-demographic variables.  In order to determine 
the role of urbanisation on the diet, the dietary intake of this study population were 
compared to a traditional rural diet and the diet of a comparable urban group with a 
similar socio-demographic profile.  These two communities were both part of the 
THUSA (Transition, Health and Urbanization in South Africa) study.  The THUSA study 
was a community based, cross-sectional study in the North West Province of South 
Africa.  In this study, dietary intakes of 1751 apparently healthy adult volunteers were 
obtained using the same validated quantitative FFQ as was used in this study.24  For the 
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purpose of this study, the data from the THUSA study was stratified into rural and a 
comparable urban group (those living in brick houses in townships with the same 
urbanisation stratum), as well as cases selected that were in the same age group (30 to 70 
yrs) and BMI range (20 to 47 kg/m2) as the study population.  Differences between the 
three groups were determined using ANOVA with Tukey’s Honest Significance test for 
unequal means, as a post-hoc test. 
 
RESULTS 
 
The biochemical characteristics of the study population are shown in Table I.  
Statistically significant differences were found between the number of smokers, blood 
pressure, LDL-cholesterol levels, LDL size, as well as fasting glucose and c-reactive 
protein (CRP) levels of the CAD patients and the control group.   
 
Table 1:  Biochemical characteristics of study population 
 CAD patients 
n = 40 
Control 
n = 20 
P value 
Gender (men/women) 33/7 13/7  
Age (years) 55 [51 - 61] 49.5 [44.5 – 57.5] 0.07 
BMI (kg/m2) 28 [24.5 - 31] 27.5 [24.5 – 33.5] 0.73 
Waist circumference (cm) 98 [88.5 - 106] 94 [83 – 100.5] 0.23 
Smoking (n) 14 (35%) 2 (10%) 0.02 
Hypertension (n) 38 (95%) 15 (75%) 0.02 
Total cholesterol (mmol/L) 5.42 [4.63 – 6.1] 4.63 [3.88 – 5.38] 0.09 
HDL cholesterol (mmol/L) 1.14 [0.98 – 1.39] 1.15 [0.95 – 1.41] 0.34 
LDL cholesterol (mmol/L) 3.31 [2.64 – 4.07] 2.85 [2.2 – 3.5] 0.005 
Triglycerides (mmol/L) 1.38 [1.03 - 2.23] 1.44 [1.02 – 1.64] 0.05 
Metabolic Syndrome (n) 24 (60%) 8 (40%) 0.14 
LDL size (n with small LDL) 29 (73%) 3 (15%) <0.0001 
Fasting glucose (mmol/L) 5.11 [4.7 – 5.4] 4.6 [3.9 – 5.1] 0.009 
Hs-CRP (mg/L) 4.72 [2.48 – 2.32] 2.32 [0.91 – 4.46] 0.026 
Data expressed as median [25 – 75 percentile] 
CAD: coronary artery disease, BMI: body mass index, HDL: high-density lipoprotein; LDL: low density 
lipoprotein; CRP: c-reactive protein levels. 
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The Metabolic Syndrome as classified by the International Diabetes Federation25 was 
present in 24 (60%) of the CAD patients compared to 8 (40%) of the controls.  Although 
this is a marked difference, it was not found to be statistically significant.  Details 
pertaining to this high prevalence of Metabolic Syndrome in the CAD cases have been 
published elsewhere.5 
 
Table 2:  Comparison of dietary intake between CAD patients, controls and 
dietary recommendations for prevention of CAD. 
 RECOMMENDATIONS  CAD PATIENTS CONTROLS 
ENERGY (kJ) Balance calorie intake and 
physical activity to achieve 
or maintain a healthy body 
weight26 10470 [9138 – 12462] 10113 [8072 – 11481] 
PROTEIN  
% of TE 
± 15 % of TE26 
12.82  [12.03 – 15.74] 
13.22 [12.87 – 15.43] 
CARBOHYDRATE  
% of TE 
50 - 60% of TE27 
55.67 [50.6 – 57.9] 
53.45 [ 48.9 – 56.54] 
TOTAL FAT  % of TE 25-35% of TE7 26.77 [23.74 – 31.67] 28.17 [ 26.84 – 33.84] 
SATURATED FATTY 
ACIDS   % of TE 
 
<7% of TE26,27,7 7.45 [6.67 – 9.5] 8.63 [7.23 – 11.36] 
TRANS FATTY ACIDS 
% of TE 
 
< 1%26,27,7 0.65 [0.52 – 1.38] 0.96 [0.61 – 1.29] 
CHOLESTEROL(mg) < 200mg27,7 298 [265 – 371] 312 [176 – 502] 
POLY 
UNSATURATED 
FATTY ACIDS  % of 
TE 
Up to 10 % of TE27 
7.2 [5.36 – 8.23] 7.15 [5.82 – 8.36] 
MONO-
UNSATURATED 
FATTY ACIDS  % of 
TE 
Up to 20 % of TE27 
9.29 [8.36 – 11.31] 10.21 [8.35 – 10.66] 
FIBRE (g) > 25g per day27,7 21.5 [17.3 – 30.7] 20.1 [15.1-26.6] 
SUGAR (g) Minimize intake of foods 
and beverages with added 
sugars26  64.9[51.2 – 98.5] 55.1 [30.7 – 110.4] 
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SALT (g) Chose and prepare food 
with little or no salt 
2.3g/day – sodium26  1722 [1362 – 2103] 
 
 
2070 [1587 – 2593] 
ALCOHOL If you do – in moderation 
2 drinks per day – men 
1 drink per day – woman26,7 
0 [0 – 9.4] 
Men: 1.9 [0.00 – 10.5]* 
Women:0 [0.00 – 0.00] 
0 [0 – 2.4] 
Men: 1.15 [0.00 – 4.7]* 
Women:0 [0.00 – 0.00] 
SELENIUM (mg) 55 mg28 41.6 [30 – 65.2] 40.8 [27 – 57.2] 
VITAMIN C (mg) 
Men: 90mg 
Women: 75mg28 
47 [33 – 81] a
Men: 45 [33 – 81] 
Women: 54 [30 – 175] 
94 [55 – 140] a
Men: 79.5 [55 – 142] 
Women: 94 [58 – 134] 
FOLATE (mcg) 400mcg28 276 [195 – 344] 221 [207 – 304] 
VITAMIN E (mg) 
15mg28 
10.22 [7.19 – 15.97] 
 
11.13 [7.01 – 14.15] 
 
VITAMIN B6 (mg) 
Men: 1.7 mg 
Woman: 1.5mg28  
1.36 [1.19 – 1.65] 
Men: 1.37 [1.17 – 1.65] 
Women: 1.36 [1.19 – 
1.77] 
1.58 [1.22 - 1.92] 
Men: 1.49 [1.24 – 1.71] 
Women: 1.62 [1.09 – 
1.92] 
B-CAROTENE (mg) 3 – 6 mg28 3.31 [2.3 – 4.8] 2.57 [1.36 – 4.73] 
PHYSICAL ACTIVITY > 30 min exercise most days 
of the week26 
5.19 [4.21 – 6.29] 4.25 [3.36 – 5.29] 
INCOME   3 [3 – 6] 3 [1 – 5.5] 
EDUCATION  3 [2 – 5] 3.65 [2 – 5] 
HOUSING(brick/ 
informal)  
37/3 19/1 
a: P = 0.049  PAI: Physical activity index; % of TE: percentage of total energy 
* Equivalent to less than 1 unit of alcohol per day 
Income categories: 2:R101-500; 3:R501-1000; 4:R1000-2000. 
Education categories: 2:< std 6; 3: Std 6-8; 4: Std 6-8 plus trade; 5: Std 9-10 
 
The macronutrient distribution was within the recommended ranges for prevention of 
CAD for both groups.  Although total fat intake is within recommended ranges, the 
saturated fatty acid intake and cholesterol intake were above the recommended ranges, 
while the intake of fibre, folate, selenium, vitamin B6 and E were all below the 
recommended intake, for both the CAD patients and the healthy volunteers.  The vitamin 
C intake of the healthy volunteers was however within the DRI range (94mg) while that 
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of the CAD patients was well below (47mg).  No correlations were found between 
biochemical variables and diet, PA or socio-demographic variables. 
 
The dietary intake, PA and socio-demographic information of the CAD patients and 
control group are reported in Table 2 and compared to the dietary guidelines for the 
prevention of CAD.  The guidelines were compiled using various existing dietary 
guidelines, to ensure that all variables would have a guideline for comparison.7,26,27,28 
When comparing the dietary intake of the CAD patients to the control group, the only 
nutrient that was found to be significantly different was the vitamin C intake (p=0.049).  
No differences were found in PA, income, and type of housing or education level 
between the groups.  Both the CAD patients and the control group had a median PAI that 
fell in the moderately active category for PA. 
 
The dietary intake of the study population is compared to the THUSA urban and rural 
groups in Table 3.  The mean dietary intake of our study population was significantly 
higher than that of both the rural and urban groups for energy, percentage of protein and 
carbohydrate of total energy, as well as dietary fibre and vitamin C.  The percentage of 
energy coming from total fat, saturated fat and mono-unsaturated fat did not differ 
between the THUSA urban and the study population, but were however significantly 
higher compared to the THUSA rural group.   
 
When looking at PA, both the THUSA rural and urban groups had a mean PAI level that 
fell in the inactive category, while the study population’s mean PAI fell in the moderately 
active group.  Significant differences were found for income, between all 3 groups, with 
the study population being in the highest category.  
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Table 3:  Comparison of dietary intake, physical activity and socio-demographic 
information of study population to rural and urban strata from THUSA 
study. 
 THUSA Rural 
(n = 250) 
THUSA Urban 
(n = 248) 
Study population 
(n = 60) 
P value 
Energy (kJ) 8368.7±3519.5a 8511±3469.17b 10752±2952.71ab <0.001 
Protein (% of TE) 12.03±2.22ab 12.66±2.47ac 13.92±2.45bc <0.001  
Fat (% of TE) 22.86±7.09ab 27.36±7.50a 27.64±5.60b <0.001 
Carbohydrate (% of TE) 65.13±9.36ab 58.76±10.03ac 53.91±5.19bc <0.001 
Saturated fat (% of TE) 6.98±3.08ab 8.42±2.97a 8.41±2.29b <0.001 
MUFA (% of TE) 7.45±2.68ab 9.48±2.99a 9.69±2.39b <0.001  
PUFA (% of TE) 6.25±2.18a 6.98±2.22a 7.07±2.00 0.039 
Total trans fatty acids (g) 1.17±0.94ab 1.63±1.41a 1.19±1.05b <0.001 
Cholesterol (mg) 269.82±194.39a 340.92±210.74a 349.79±191.42 0.011 
Alcohol (g) 7.98±26.71 12.02±(39.61) 4.42±8.66 0.4 
Total dietary fibre (g) 16.47±8.15a 17.33±8.34b 23.14±9.12ab <0.00001 
Vitamin C (mg) 30.31±31.11ab 40.37±41.17ac 86.27±69.49bc <0.001  
Vitamin E (mg) 10.10±4.94 11.57±6.81 12.08±6.07 0.29 
Income 2.41±1.1ab 2.933±1.32ac 3.58±1.9bc <0.0001 
Physical activity (PAI) 2.43±0.76a 2.72±1.10b 5.33±2.29ab <0.001  
TE: Total energy; MUFA: mono-unsaturated fatty acids; PUFA: poly-unsaturated fatty acids; PAI: physical 
activity index 
Data presented as mean±SD 
Mean values with the same superscript letter differ significantly p≤ 0.05 determined with post-hoc tests 
Income: Categories: 2:R101-500; 3:R501-1000; 4:R1000-2000. 
 
DISCUSSION  
 
The definite increase in the known risk factors for CAD, as well as the increase in CAD 
observed in the black South African urbanised population prompted this study.  In order 
to determine the role of the diet in this increased prevalence of both the risk factors and 
the disease, the dietary intake of age and BMI matched CAD patients and a control group 
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were compared.  No significant difference in diet, PA and socio-demographics was found 
between the CAD patients and control group, except for vitamin C intake.   
 
When comparing the two groups to the dietary guidelines for prevention of CAD, the 
results suggest that the study population as a whole possibly has a suboptimal fruit and 
vegetable intake (due to low fibre and micronutrient intake), as well as a saturated fat and 
cholesterol intake above the recommended intake.  This trend was also seen in the 
INTERHEART study, results of which suggest that increased consumption of fruit and 
vegetables and a reduced intake of fried foods, probably related to type of fat used for 
frying and salty snacks is likely to reduce the risk of MI in all regions of the world.29   
 
The INTERHEART Africa study found that known CVD risk factors account for ≈ 90% 
of MI observed in African populations (smoking history, diabetes history, hypertension, 
abdominal obesity and ratio of apolipoprotein B to apolipoprotein A-1).12  Evidence from 
prospective studies have also shown that dietary patterns are associated with increased 
risk for CHD.8  It has also been observed that there have been shifts in dietary intake of 
the black South African population over the past 2 decades to a more westernised 
diet.10,13  Appropriate fibre, folate, vitamin E and vitamin C intake have been associated 
with a reduced cardiovascular risk in prospective studies, however when the effect of 
some of these nutrients, for example their anti-oxidant capacity were tested individually 
in clinical trials, the results were not significant.30  This has led to a shift from looking at 
individual nutrients and supplementation to rather looking at food-based hypotheses and 
the cardioprotective properties of fruit and vegetables as a whole.31,32  The consumption 
of fruit and vegetables, particularly green leafy vegetables and vitamin C rich fruit and 
vegetables appears to have a protective effect against CHD.32,33,34 
 
The macronutrient intake of both the CAD patients and the controls compared well with 
the guidelines for the prevention of CAD, with only saturated fatty acids and cholesterol 
being higher than the guideline, although only marginally for both groups. These results 
suggest that for this population, the development of CAD was not related to increased 
macronutrient intake. The micronutrient intake for both groups was below the 
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recommendations, except the vitamin C intake of the healthy volunteers, which was 
within the DRI range (94mg). Vitamin C, besides being an antioxidant also promotes fast 
regeneration of the endothelium after tissue injury, which is of importance during 
secondary prevention as well as early development of CAD.35 This suggests that while no 
differences exist in the macronutrient intake between the two groups, difference in 
micronutrient intake may contribute to the development of CAD.  This is supported by 
the fact that in the INTERHEART study, a low fruit and vegetable intake (as rich sources 
of micronutrients) was found to be one of the leading causes of CAD. 12 There is 
however, also the possibility that the control group may still develop CAD. Although not 
significantly so, the control group (49.5 years) had a younger median age than the CAD 
patients (55 years).  These ages are similar to the ages that were reported in the 
INTERHEART Africa study for control subjects (50.6 years) and those that have 
developed CAD (53 years).12 It is a possibility that by the time the controls reach the 
same age as the cases, they may also develop CAD. 
 
When this study population’s dietary intake, PA and socio-demographics were compared 
to another South African population group, some differences were found. As would be 
expected based on their level of urbanisation, their dietary intake, income and PA 
differed from the traditional rural group.  The higher fat consumption in our study 
population is consistent with other findings10 that show that there is an increase in fat 
intake with urbanisation, however the percentage fat intake is still well within the 
recommended intake and not as high as the typical westernised diet.10 The study 
populations’ dietary intake was however also higher for most nutrients than the THUSA 
urban group.  Despite having the same socio-economic status and being in the same level 
of urbanisation, the study population fell in a higher income category than the THUSA 
urban group.  Maize meal was the staple food with a low fruit and vegetable intake24 
common in all three groups.  However, in both the THUSA rural and urban group, more 
than half the protein intake was derived from plant sources, while the opposite was found 
in this study population with almost 60% coming from animal sources. 
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When looking at PA, both the rural and urban groups from the THUSA study fell in the 
inactive category, while the study population fell in the moderately active group.  The 
low PA in the THUSA group may be explained by the fact that traditionally living rural 
people do not expend energy without a purpose, namely to perform a task.16 In our study 
population, few owned their own form of transport and spent energy walking to taxi 
ranks or to work, which possibly explains their higher PA level and possibly contributes 
to the observed increased dietary intake. 
 
A limitation of this study was the fact that the CAD patients had to be at least 3 months 
post MI before being included in this study.  This could have resulted in the patients 
having changed their habitual dietary intake in the interim, as dietary education is a 
standard part of the hospital treatment following a MI. 
 
CONCLUSION 
 
Little is known about the causes of CAD in the black South African population.  When 
confounding factors age and obesity were accounted for, there were no differences in the 
diet, physical activity or socio-demographics of the CAD patients and control group, 
except for vitamin C intake.  The macronutrient intake of both groups was within 
recommendations, while both groups had a micronutrient intake below the recommended 
level. While diet is known to be affected by urbanisation, differences in dietary intakes 
were observed between the two urban groups, regardless of the similarity in their socio-
demographic profile.  
 
ACKNOWLEDGEMENT 
 
This study was supported in part by the Circulatory Disorders Research Fund. 
 
REFERENCES 
 
  
 
48
1. Yusuf S, Reddy, S, Ôunpuu, Anand, S.  Global burden of cardiovascular diseases.  
Part II: Variations in cardiovascular disease by specific ethnic  groups and 
geographic regions and prevention strategies.  Circulation  2001; 104:2855-2864. 
 
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL.  Global and regional 
burden of disease and risk factors, 2001: systematic analysis of population health 
data.  Lancet 2006; 367:1747-1757. 
 
3. Seftal HC.  The rarity of coronary heart disease in South African Blacks.  S Afr 
Med J 1978; 54:99-105. 
 
4. Sliwa K, Wilkinson D, Hansen C, Ntyintyane LM, Tibazarwa K, Becker A, Stewart 
S.  Spectrum of heart disease and risk factors in a black urban population in South 
Africa (the Heart of Soweto Study): a cohort study.  Lancet 2008; 371:915-922, 
March. 
 
5. Ntyintyane LM, Panz VR, Raal FJ, Gill GV.  Metabolic syndrome, undiagnosed 
diabetes mellitus and insulin resistance are highly prevalent in urbanised South 
African Blacks with coronary artery disease.  Cardiovasc J S Afr 2006; 17(2): 7-12. 
 
6. Yusuf S, Reddy, S, Ôunpuu, Anand, S.  Global burden of cardiovascular diseases.  
Part I: General considerations, the epidemiological transition, risk factors and 
impact of urbanization.  Circulation 2001; 104:2476-2753. 
 
7. Van Horn L, McCoin M, Kris-Etherton PM, Burke F, Carson JS, Champagne CM 
et al.  The evidence for dietary prevention and treatment of cardiovascular disease.  
J Am Diet Assoc 2008; 108: 287 – 331. 
 
8. Krauss RH, Eckel B, Howard LJ, Appel SR, Daniels RJ, Deckelbaum JW et al.   
AHA Dietary guidelines.  Revision 2000: A statement for healthcare professionals 
  
 
49
from the nutrition committee of the American Heart Association.  Circulation 2000; 
102:2284-2299. 
 
9. Hu FB, Rimm EB, Stampfer MJ, Asherio A, Spiegelman D, Willet WC.  
Prospective study of major dietary patterns and risk of coronary heart disease in 
men.  Am J Clin Nutr 2000; 79:912-921. 
 
10. Bourne LT, Lambert EV, STEYN K.  Where does the black population of South 
Africa stand on the nutrition transition?  Public Health Nutr 2002; 5(1A): 157-162. 
 
11.  Vorster HH, Kruger A. Venter CS, Margetts BM, MacIntyre UE.  Cardiovascular 
disease risk factors and socio-economic position of Africans in transition: the 
THUSA study.  Cardiovasc J Afr 2007; 18(5):282-289. 
 
12. Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, Damasceno A et al.    Risk 
factors associated with myocardial infarction in Africa: The INTERHEART Africa 
study.  Circulation 2005; 112:3554-3561. 
 
13. Vorster HH, Venter CS, Wisssing MP, Margetts BM.  The nutrition and health 
transition in the North West Province of South Africa: a review of the THUSA 
(Transition and Health during Urbanisation of South Africans) study.  Public Health 
Nutr 2005; 8(5): 480 –490. 
 
14. Thompson PD, Lim V.  Physical activity in the prevention of atherosclerotic 
coronary heart disease.  Curr Treat Options Cardiovasc med 2003; 5: 279-285. 
 
15. Levitt NS, Steyn K, Lambert EV, Fourie JM, Rossouw K.  Modifiable risk factors 
for Type 1 diabetes mellitus in a peri-urban community in South Africa.  Diabetes 
med 1999; 16:1-5. 
 
  
 
50
16. Kruger HS, Venter CS, Vorster HH.  Physical inactivity as a risk factor for 
cardiovascular disease in communities undergoing rural to urban transition: the 
THUSA study.  Cardiovasc J S Afr 2003; 14: 16-23. 
 
17. Friedewald WT, Levy RI, Frederickson DS.  Estimation of the concentration of low 
density lipoprotein cholesterol in plama, without use of the preparative cnetrifuge.  
Clin Chem 1972; 18:499-502. 
 
18. MacIntyre UE, Venter CS, Vorster HH.  A culture-sensitive quantitative food 
frequency questionnaire used in an African population: 1.  Development and 
reproducibility.  Public Health Nutr 2000; 4(1): 53-62.   
 
19. Venter CS, MacIntyre UE, Vorster HH.  The development and testing of a food 
portion photograph book for use in an African population.  J Hum Nutr Diet 2000; 
13(3): 205-218. 
 
20. Langenhoven ML, Kruger M, Gouws E, Faber M.  MRC food composition tables.  
3rd Ed.  Cape Town:  Medical research Council 1991. 
 
21. Kruger HS, Venter CS, Steyn HS.  A standardised physical activity questionnaire 
for a population in transition: the THUSA study.  AJPHERD 2000, 6(1): 54-64, 
Apr. 
 
22. Kruger HS, Venter CS, Vorster HH.  Physical inactivity as a risk factor for 
cardiovascular disease in communities undergoing rural to urban transition: the 
THUSA study.  Cardiovasc J  S Afr 2003; 14: 16-23. 
 
23. StatSoft, Inc. (2007). STATISTICA (data analysis software system), version 8.0. 
www.statsoft.com  
 
  
 
51
24. MacIntyre, UE, Kruger HS, Venter CS, Vorster HH.  Dietary intakes of an African 
population in different stages of transition in the North West Province, South 
Africa: the THUSA study.  Nutrition Research 2002; 22:239-256. 
 
25. International Diabetes Federation, The IDF consensus worldwide definition of the 
metabolic syndrome, http://www.idf.org/webdata/docs/IDF Metabolic syndrome 
definition.pdf. 
 
26. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA et al. 
Diet and lifestyle recommendations revision 2006.  A scientific statement from the 
American heart Association Nutrition committee.  Circulation 2006; 114: 82-96. 
 
27. NCEP 2001. Executive summary of the third report of the NCEP expert panel on 
detection, evaluation and treatment of high blood cholesterol in adults. JAMA 285 
(19): 2486 – 2497. 
 
28. NICUS.  Dietary Reference Intakes.  National Academy Press; 2003. 
 
29 Iqbal R, Anand S, Ounpuu S, Islam S, Zhang X, Rangarajan S et al.  Dietary 
patterns and the risk of acute myocardial infarction in 52 countries.  Results of the 
INTERHEART study.  Circulation 2008, 111: 1929-1937. 
 
30. Sesso HD, Buring JE, Christen WG et al.  Vitamins E and C in the prevention of 
cardiovascular disease in men.  JAMA 2008; 300(18): 2123-2133. 
 
31. Ness AR, Powles JW.  Fruit and vegetables, and cardiovascular disease: A review.  
Int J Epidemiol 1997; 26(1):1-13 
 
32. Bazzano LA, Serdula MK, Liu S.  Dietary intake of fruit and vegetables and risk of 
cardiovascular disease.  Curr Atheroscler Rep 2003 5(6): 492-499. 
 
  
 
52
33. Joshipura KJ, Hu FB, Manson JE, Stampfer MJ, Rimm EB, Speizer FE et al.  The 
effect of fruit and vegetable intake on risk for coronary heart disease.  Ann Intern 
Med 2001; 134:1106-1114.  
 
34. Dauchet L, Ferrieres J, Arveiler D, Yarnell JW, Gey F, Ducimetiere P et al.  
Frequency of fruit and vegetable consumption and coronary artery disease in France 
and North Ireland: the PRIME study.  Br J Nutr 2004; 92:963-972. 
 
35. Ulrich-Merzenich G, Zeitler H, Panek D, Bokemeyer D, Vetter H.  Vitamin C 
promotes human endothelial cell growth via the ERK-signaling pathway.  Eur J 
Nutr 2007; 46:87-94. 
 
